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The gastrointestinal tract is of central importance, due to its role in digestion, nu-
trient uptake and as a first line of defense against microbial and parasitic food 
contaminants. The intestine is the longest section, in which these processes take 
place. Its inner lining, the intestinal epithelium is a complex tissue with highly di-
verse cell types. The cellular turnover is the fastest in the human body, the entire 
epithelium completely renews itself every 4 to 7 days. Consequently, intestinal 
epithelial proliferation and differentiation need to be carefully balanced to main-
tain homeostasis, a process in which intestinal stem cells play a crucial role. Once 
disturbed, a plethora of intestinal diseases develop, including colorectal cancers, 
which account for 10 % of new cancer cases every year. The semaphorin-plexin 
system consists of a family of ligands, the semaphorins and their corresponding 
receptors, the plexins. These molecules have been described to play an im-
portant role in epithelial homeostasis in other organs and are known to be in-
volved in cancer development. Since plexins B1 and B2 are known to be ex-
pressed in the intestine, the expression of their class 4 semaphorin ligands and 
angiogenin in the intestinal epithelium was systematically analyzed. These ex-
periments revealed the ligands to be expressed in partially overlapping patterns. 
Next, a bacterial artificial chromosome was constructed to express Cre under the 
enterocyte-specific Alpi promoter. This construct enabled the generation of a 
novel Alpi-Cre mouse line for future breeding of enterocyte-specific knockout 
mice. Studying stem cell function, intestinal crypts were isolated from Plexin 
B1/B2 knockout mice and analyzed for their ability to form organoids. Organoid 
formation was reduced, pointing to a defect in stem cell function. To identify the 
relevant ligands, semaphorin knockout organoids were analyzed in the same 
manner, but failed to replicate the receptor knockout phenotype. To target multi-
ple ligands simultaneously by inducible RNAi, a lentiviral transduction method 
was established for future organoid studies. To explore the role of semaphorins 
in human intestinal physiology and disease, colonic organoids from normal and 
tumor tissue samples of patients were established. These results precisely lay 
out the overlapping expression patterns of B-plexin ligands in the intestinal epi-
thelium, highlight their redundancies, and enable further functional studies, in-




Der Gastrointestinaltrakt ist aufgrund seiner Rolle in der Verdauung und Absorp-
tion von Nährstoffen und als erste Verteidigung gegen mikrobielle und parasiti-
sche Krankheitserreger von zentraler Wichtigkeit. Der Darm ist der längste Ab-
schnitt und erfüllt diese Aufgaben. Sein Epithel ist ein komplexes Gewebe mit 
diversen Zelltypen, das sich in 4 bis 7 Tagen vollständig erneuert. Um dessen 
Homöostase zu wahren, müssen Proliferation und Differenzierung im Gleichge-
wicht sein, wobei die intestinalen Stammzellen eine zentrale Rolle spielen. Wird 
die Homöostase gestört, entwickeln sich Krankheiten, u. a. kolorektale Tumore, 
die jährlich 10 % aller neuen Krebserkrankungen ausmachen. Das Semaphorin-
Plexin-System besteht aus einer Liganden-Familie, den Semaphorinen und de-
ren Rezeptoren, den Plexinen. Dieses System ist ein Regulator epithelialer Ho-
möostase in anderen Organen, sowie in der Tumorentstehung. Da Plexin B1 und 
B2 im Darm exprimiert sind, wurde die Expression relevanter Klasse-4-Sema-
phorin-Liganden, sowie von Angiogenin im Darmepithel systematisch analysiert. 
Hierbei wurden sich überschneidende Expressionsmuster entdeckt. Weiterhin 
wurde ein bakterielles artifizielles Chromosom konstruiert, um Cre-Rekombinase 
unter der Kontrolle des enterozyten-spezifischen Alpi-Promotors zu exprimieren. 
Dieses Konstrukt ermöglichte die Zucht eines neuen Alpi-Cre Mausstamms, mit 
dem Ziel, zukünftig enterozyten-spezifische Knockout-Mäuse zu generieren. Die 
Funktion intestinaler Stammzellen wurde analysiert, indem Darmkrypten von Ple-
xin B1/B2 Doppelknockout-Mäusen isoliert und in Kultur genommen wurden. De-
ren reduzierte Fähigkeit, Organoide auszubilden, wies auf einen Defekt der 
Stammzell-Funktion hin. Semaphorin-Knockout-Organoide wurden analysiert, 
um die zugehörigen Liganden zu identifizieren, replizierten den Phänotyp des 
Rezeptor-Knockouts allerdings nicht. Zudem wurde die lentivirale Transduktion 
von Organoiden etabliert, um mittels RNAi die Expression mehrerer Liganden 
gleichzeitig reduzieren zu können. Ferner wurden Kolon-Organoide aus gesun-
dem Gewebe und Tumorproben von Patienten etabliert, um die Funktion der Se-
maphorine in menschlichem Darmepithel und dessen Erkrankungen zu untersu-
chen. Diese Ergebnisse zeigen überlappende Expressionsmuster der B-Plexin-
Liganden im Darm, legen deren Redundanz dar und ermöglichen weitere funkti-




1.1 The gastrointestinal tract 
The gastrointestinal (GI) tract is the body’s organ system tasked with the 
mechanical and chemical breakdown of food into single-molecule nutrients that it 
absorbs through the epithelium (H. Karasov & Douglas, 2013). It is structured as 
a tubular series of organs, starting at the oral cavity, continuing through the 
esophagus, the stomach, the small intestine, the large intestine or colon, and 
terminates at the anus, where the remains of the digestive process are excreted. 
Beyond providing nutrients, the GI tract presents a border for pathogens entering 
the body, regulates the body’s metabolism through hormones, and directly inter-
acts with the nervous system. Most of the GI tract is structured in four major his-
tological layers. The mucosa forms the innermost layer lining the organ’s lumen. 
It consists of a simple columnar epithelium sitting on a layer of connective tissue, 
the lamina propria and a layer of muscle, the lamina muscularis mucosae. The 
epithelium comes into direct contact with the intestine’s contents and fulfills a 
multitude of functions of which the most prominent is the absorption of nutrients 
from the intestinal contents. The submucosa is a layer of connective tissue and 
blood vessels located beneath the mucosa and facilitates the supply of oxygen 
to the epithelium and the transport of most absorbed substances from the intes-
tine into the rest of the body. Furthermore, the submucosal or Meissner’s plexus 
innervates the inner intestinal wall, communicating with both epithelial cells and 
the muscularis mucosae. Next, the muscularis provides contractility to the GI 
tract: Two layers of smooth muscle, one concentric and one longitudinal, allow 
for the contraction of the organs in peristaltic movement, pushing intestinal con-
tents along. Motor control of these muscles is provided by the myenteric or Auer-
bach’s plexus, consisting of a network of ganglia, that is part of the enteric nerv-
ous system. Finally, the GI tract’s outermost layer is formed by either the adven-
titia or serosa, both layers of connective tissue. 
 
1.1.1 Anatomy and function of the small and large intestine 
The GI tract’s longest sections are the small and large intestine. At the proximal 
end, the small intestine (SI) connects to the stomach’s pyloric region and is struc-
tured into three sections from proximal to distal, termed the duodenum, jejunum, 
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and ileum. At its distal end, the ileocecal valve marks the transition into the large 
intestine, which is sectioned into the cecum, the ascending colon, transverse co-
lon, descending colon, sigmoid colon, and rectum, before it terminates at the 
anus. Both small and large intestine are characterized by intestinal crypts or 
crypts of Lieberkühn, glandular structures initially described by Jonathan Nathan-
ael Lieberkühn (Lieberkühn, 1745). Lined with epithelium, they extend into the 
submucosa of the intestinal wall and provide the intestinal stem cell niche. Func-
tionally, in the duodenum proteins, lipids, and carbohydrates are prepared for 
absorption by enzymatic breakdown. The jejunum is the section of the small in-
testine where most absorption of nutrients takes place. A special role in this task 
falls to the villi, finger-like protrusions extending into the lumen: They vastly ex-
tend the intestine’s luminal surface area and house both capillaries and lymphatic 
vessels that transport absorbed molecules into the body (Clevers, 2013). Im-
portantly, vitamin B12 is absorbed in the ileum (LeBlanc et al., 2013). The colon 
is tasked with the absorption of water and bile salts from the intestinal contents. 
In addition, vitamin K produced by colonizing microbiota is absorbed here (Hill, 
1997). Through these processes, the intestinal contents solidify, are gathered in 
the rectum, and ultimately excreted through the anus. 
 
1.1.2 The intestinal epithelium 
The intestinal epithelium is a simple columnar epithelium, lining the lumen of the 
small and large intestine and serves as the first barrier to all contents passing 
through the intestine. Due to the stresses the epithelium endures, both physical 
and chemical, it is the tissue with the highest cellular turnover in the human body, 
the entire epithelial layer completely renews itself within four to seven days (Ste-
vens & Leblond, 1947). 
To fulfill the intestine’s multitude of duties, the organ relies on a quickly prolifer-
ating, highly dynamic, and diverse population of epithelial cells that originate from 
the crypts of Lieberkühn where the intestinal stem cell pool is located (Barker et 
al., 2007). As these cells divide once every day, excess cells are randomly 
pushed out of the stem cell niche, thus migrating upwards (Snippert et al., 2010)⁠. 
These progenitor cells form the transit-amplifying (TA) zone, where they divide 4-
5 times before committing to the absorptive or secretory lineage and differentiate 
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into a number of highly specialized cell types (Figure 1) (Spit et al., 2018; van der 
Flier & Clevers, 2009). As they mature, the cells continue moving towards the 
villus tip where they become apoptotic and are shed into the intestinal lumen (Hall 
et al., 1994). 
 
  
Figure 1 The intestinal epithelium. From (Spit et al., 2018), licensed under CC BY (https://crea-
tivecommons.org/licenses/by/4.0/). 
 
1.1.2.1 The intestinal stem cell niche 
At the crypt’s bottom the intestinal stem cells (ISCs), also called crypt base co-
lumnar cells (CBCs), are interspersed with Paneth cells to form the stem cell 
niche (Bjerknes & Cheng, 1981; Cheng & Leblond, 1974) ⁠. Under homeostatic 
conditions, all intestinal epithelial cells originate from these ISCs (Barker et al., 
2007). The intestinal stem cell niche is supported by multiple cell types, Paneth 
cells contribute crucial nutrients and growth factors like Wnt, epidermal growth 
factor (EGF), and delta-like canonical notch ligand 4 (DLL4), which are required 
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for the maintenance of the stem cell pool (Rodríguez-Colman et al., 2017; Sato, 
van Es, et al., 2011) ⁠. In addition, subepithelial telocytes and myofibroblasts also 
produce Wnt ligands preserving stemness (Shoshkes-Carmel et al., 2018; 
Valenta et al., 2016). Further niche factors include R-Spondins, which are Wnt 
pathway activators and Noggin, an inhibitor of bone morphogenetic protein 
(BMP)-mediated differentiation (Haramis et al., 2004; Spit et al., 2018). ISCs are 
identified by the expression of leucin-rich-repeat-containing G-protein-coupled re-
ceptor 5 (LGR5) and give rise to all cells required for homeostatic renewal of the 
entire intestinal epithelium (Barker et al., 2007). Other marker genes associated 
with ISCs include the Notch target gene olfactomedin 4 (OLFM4) and achaete-
scute complex homolog 2 (ASCL2), a key Wnt target gene regulating stemness 
(Schuijers et al., 2015; van der Flier et al., 2009). The crypt’s stem cell population 
undergoes symmetrical divisions governed by neutral drift dynamics, ultimately 
producing crypts consisting of a single clone’s offspring (Lopez-Garcia et al., 
2010; Snippert et al., 2010). As ISCs regularly divide, but space at the crypt bot-
tom is limited, excess cells are pushed upwards and out of the stem cell niche to 
become progenitor cells for the two epithelial lineages (Snippert et al., 2010). The 
apical border of the stem cell niche is formed by reserve intestinal stem cells 
(rISCs) in the +4 nuclear position, named after their location within the crypt, 
counting upwards from the bottom-most nucleus (Bankaitis et al., 2018). Within 
the ISC pool, these largely quiescent rISCs represent a more damage resistant 
population marked by the expression of polycomb protein B lymphoma Mo-MLV 
insertion region 1 homolog (BMI1) (Sangiorgi & Capecchi, 2008; K. S. Yan et al., 
2012). Other biomarkers have since been associated with reserve stem cells, 
including homeobox-only protein (HOPX) in a study by Takeda et al., that demon-
strated reserve and actively cycling ISCs to be interconvertible (Takeda et al., 
2011). These reserve stem cells are non- or slowly proliferating under homeo-
static conditions but contribute a large number of epithelial cells after injury, cru-
cially including LGR5-positive ISCs, demonstrating their ability to fully restore the 
intestinal epithelium (Sangiorgi & Capecchi, 2008; Takeda et al., 2011; Tian et 
al., 2011; K. S. Yan et al., 2012). In addition, a wide range of intestinal cell types 
have been demonstrated to be capable of contributing to intestinal regeneration, 
e.g., delta-like canonical notch ligand 1 (DLL1) or SOX9-positive progenitors, 
Paneth and enteroendocrine cells, comprehensively reviewed by Bankaitis et al. 
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(Bankaitis et al., 2018). Furthermore, absorptive progenitors expressing the en-
terocyte marker alkaline phosphatase, intestinal (ALPI), but not terminally differ-
entiated enterocytes are able to repopulate the intestinal stem cell niche after 
injury and give rise to cells expressing stem or Paneth cell signatures (Tetteh et 
al., 2016).  
 
1.1.2.2 Intestinal epithelial differentiation 
All intestinal epithelial cells originate from ISCs at the crypt base and undergo 
differentiation into specialized cell types as they migrate upwards (Spit et al., 
2018). Two main lineages govern differentiation in the intestinal epithelium, the 
absorptive and the secretory lineage (Figure 2) (Schepers & Clevers, 2012). Cell 
fate determination is largely regulated by the Notch pathway: The transcription 
factor hes family bHLH transcription factor 1 (HES1) is a Notch target gene and 
inhibits the strongly pro-secretory transcription factor atonal bHLH transcription 
factor 1 (ATOH1) (Jensen et al., 2000; Yang et al., 2001). Thus, activation of 
Notch reduces differentiation into the secretory lineage, while inhibition of Notch 
increases the number of secretory cells in the epithelium (Fre et al., 2005; Milano 
et al., 2004; J. H. van Es et al., 2005). 
 




The absorptive enterocytes are the most numerous cell type and take up nutrients 
from the chymus, while also interacting with the intestine’s immune cells (Miron 
& Cristea, 2012; Snoeck et al., 2005). The cells of the secretory lineage are fewer 
in number but tasked with a plethora of specialized functions: Paneth cells are 
crucial in maintaining the ISC pool and provide nutrients, EGF, Wnt and Notch 
ligands, and secrete antimicrobial peptides like defensins and lysozyme (LYZ1) 
(Porter et al., 2002; Rodríguez-Colman et al., 2017; Sato, van Es, et al., 2011). 
Consequently, they migrate towards the crypt base to become part of the intesti-
nal stem cell niche (Bjerknes & Cheng, 1981; Ireland et al., 2005). Differentiation 
into Paneth cells requires expression of the Wnt pathway target gene Sox9, mak-
ing it a key regulator of the secretory lineage (Bastide et al., 2007). Goblet cells 
secrete mucin-2 (MUC2) into the intestinal lumen, a component of the mucus that 
protects the epithelium from enzymes, chemical stresses and prevents microor-
ganisms from coming into direct contact with the epithelium (Pelaseyed et al., 
2014). Enteroendocrine cells (EECs) are derived from neurogenin3-positive pro-
genitor cells (Jenny et al., 2002). They differentiate into several specialized, hor-
mone-secreting cell types, involving them directly in the local and systemic regu-
lation of digestion and metabolism (Gribble & Reimann, 2016). Despite their di-
versity, chromogranin-A (CHGA) is considered a universally expressed marker 
for EECs (Varndell et al., 1985). Additionally, they form the epithelium’s link to the 
nervous system, directly interacting with afferent neurons (Bohórquez et al., 
2015)⁠. Tuft cells are diverse, chemosensory cells, named after their apical tuft of 
microvilli and are present along the entire small and large intestine (McKinley et 
al., 2017). The expression of doublecortin-like kinase 1 (DCLK1) is generally used 
as a marker to identify these cells (Gerbe et al., 2009). While the function of tuft 
cells is incompletely understood, multiple studies assigned them a central role in 
the body’s immune response to parasitic infection (Gerbe et al., 2016; Howitt et 




1.1.3 Colorectal cancer 
Colorectal cancer (CRC) is the most common cancer of the GI tract and originates 
in the colon and rectum. Most tumors are of epithelial origin, forming adenocarci-
nomas. In 2018, CRC accounted for 10.2 % of new cancer cases worldwide, mak-
ing it the third-most common cancer behind lung and breast cancer. In the same 
year, it caused 881,000 deaths, 9.2 % of cancer-related mortality and second 
only to lung cancer. Its incidence positively correlates with the human develop-
ment index, meaning CRC is most common in more-developed regions, i.e., Aus-
tralia and New Zealand, Europe, and North America (Bray et al., 2018)⁠. People 
over the age of 60 are most strongly affected, representing 80 % of sporadic co-
lon cancer patients at diagnosis (Kuipers et al., 2015). While both genetic and 
environmental factors play a role in colorectal cancer, most cases are sporadic, 
with 75 % of patients having a negative family history. Typical environmental risk 
factors are lifestyle factors associated with several tumors: Smoking, alcohol con-
sumption, increased body weight, intake of processed food stuffs and red meat 
contribute to a risk increase (World Cancer Research Fund, 2018). The two most 
common hereditary causes of colorectal cancer are hereditary non-polyposis col-
orectal cancer (HNPCC), also known as Lynch syndrome, and familial adenoma-
tous polyposis (FAP). Together they account for ca. 5-10 % of cases⁠. While 
HNPCC is caused by defects in DNA mismatch-repair genes, FAP is caused by 
loss-of-function mutations in the gene APC regulator of WNT signaling pathway 
(APC), a negative regulator of the Wnt pathway (Lynch & de la Chapelle, 2003). 
Both syndromes lead to an early onset in tumor formation and a greatly increased 
lifetime risk. Since tumor tissue of different stages is often available from the 
same patient, the progression of CRC has been studied extensively: Generally, 
development of CRC is understood to be caused by an accumulation of muta-
tions, commonly referred to as the adenoma-carcinoma sequence (Fearon & Vo-
gelstein, 1990; Vogelstein et al., 1988). Initiation of tumor development is most 
commonly linked to a loss-of-function in the APC gene, followed by gain-of-func-
tion mutations affecting the EGFR pathway (e.g., RAS or PIK3CA mutations), 
inactivation of BMP signaling (e.g., SMAD4 mutations) and p53, ultimately facili-
tating the progression from a benign adenoma to a malign and possibly meta-
static carcinoma. The development of methods to recapitulate CRC outside of the 
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patient has been the subject of research for a long time and the first patient-de-
rived tumor xenografts (PDTX) were established in the early 1950s (Toolan, 
1953)⁠. The method has been advanced substantially since then and offers the 
advantage of providing the tumor microenvironment as well, but also has its draw-
backs. Since only small amounts of tissue can be transplanted, a tumor’s heter-
ogeneity might not be fully captured and some studies reported additional muta-
tions in the xenograft, that were not present in the original tumor (Bleijs et al., 
2019; Morgan et al., 2017). Furthermore, engraftment rates depend on the parent 
tumor’s staging and as xenografts are passaged, clonal selection of tumors takes 
place and the patient’s stroma will eventually be lost (Bleijs et al., 2019) ⁠. Lastly, 
PDTXs rely on the use of laboratory animals, making this method to replicate 
patient-derived tumors relatively complex. More recently, the development of or-
ganoid cultures derived from human intestinal tissues has opened new avenues 
in the study of CRC, as patient-derived tissues can be cultured and manipulated 
ex vivo without the reliance on animal models (Sato et al., 2009; Sato, Stange, et 
al., 2011). A more detailed introduction to organoids is provided in section 1.4. 
 
1.2 The semaphorin-plexin system 
The semaphorin-plexin system consists of two families of cell-cell signaling pro-
teins first discovered in the nervous system: Semaphorins represent the ligands, 
and plexins the receptors (Bamberg et al., 1999). The functions assigned to these 
molecules have vastly expanded since: Among others, they are important in or-
gan development of the brain and kidney, epithelial homeostasis, immune sys-
tem, and bone turnover and have been described to be involved in pathological 
processes, including cancer (Worzfeld & Offermanns, 2014). More recently, an-
giogenin (ANG) has been described to be a ligand to plexin B2, expanding an 




Figure 3 Class 4 semaphorins, angiogenin and their plexin receptors. 
 
1.2.1 Ligands of the semaphorin-plexin system 
Semaphorins are a large family of transmembrane and secreted ligands, orga-
nized in eight classes, 1-7 and V, of which classes 1 and 2 appear in inverte-
brates, 3 to 7 are present in vertebrates and class V semaphorins were discov-
ered in viruses (Bamberg et al., 1999). All semaphorins are characterized by a 
common structural property, the ca. 500 amino acid N-terminal sema domain, 
and the plexin-semaphorin-integrin (PSI) domain, both of which are located ex-
tracellularly (Figure 3) (Kolodkin et al., 1993). The sema domain is essential for 
semaphorin-plexin signaling: First, it enables the homodimerization of sema-
phorins (Klostermann et al., 1998; Love et al., 2003). Second, it mediates plexin 
receptor binding: Semaphorin homodimers bind two monomeric plexin molecules 
via their sema domain, bring them into proximity and activate intracellular signal-
ing (Janssen et al., 2010; Nogi et al., 2010). In class 3 semaphorins, the 
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semaphorin homodimer binds two receptor heterodimers consisting of a plexin 
and a neuropilin co-receptor (Janssen et al., 2012). While semaphorin-plexin in-
teractions often take place between membrane-bound molecules, there are ex-
ceptions to that rule: Class 3 semaphorins are secreted ligands, and the extra-
cellular domain of class 4 semaphorins may be liberated by proteolytic cleavage, 
enabling them to act as soluble ligands (Elhabazi et al., 2001; Hemming et al., 
2009; Nakatsuji et al., 2012; Xiaosong Wang et al., 2001). Beyond their roles as 
ligands, semaphorins can also function as receptors (Gurrapu et al., 2019; Sun 
et al., 2017). Semaphorins regulate a wide range of physiological processes in 
the nervous and immune system, epithelial architecture, as well as angiogenesis 
(C. Gu & Giraudo, 2013; Kumanogoh & Kikutani, 2013; Neufeld et al., 2012; Pas-
terkamp, 2012; Potiron et al., 2007; Xia et al., 2015). Furthermore, semaphorins 
play a role in pathological mechanisms as well, influencing tumor growth directly 
by acting on the malignant cell, or indirectly e.g., by regulating angiogenesis 
(Neufeld et al., 2012, 2016). Previous publications, as well as unpublished data 
from another doctoral candidate, Ivana Matković, showed the receptors plexin B1 
(PLXNB1) and plexin B2 (PLXNB2) to be highly expressed in the intestinal epi-
thelium (Meehan et al., 2014; Xia et al., 2015). Consequently, the focus of this 
thesis lies on B-plexin ligands, namely semaphorins 4A, B, C, D, G, and angiog-
enin.  
Semaphorin 4A (Sema4A) is a membrane-bound ligand to B-plexins, plexin D1 
and TIM2 (Worzfeld & Offermanns, 2014). Originally, it was discovered together 
with several other semaphorins in the developing nervous system of mouse em-
bryos and named SemB (Püschel et al., 1995). Since its discovery, Sema4A has 
been found to be a key regulator in the in the immune system, and thus been 
termed an “immune semaphorin”, but also plays a role in angiogenesis (Ito & 
Kumanogoh, 2016). In the immune system, Sema4A is expressed on dendritic 
cells and required for efficient T-cell activation, as Sema4A-deficient mice 
showed reduced immune responses (Kumanogoh et al., 2005). Signaling through 
plexin B2, Sema4A contributes to the activation and differentiation of CD8+ 
T cells (Ito et al., 2015). In patients suffering from multiple sclerosis, Sema4A was 
found to be highly expressed in dendritic cells from which its extracellular domain 
was proteolytically cleaved, resulting in increased serum levels which were linked 
to a worse clinical outcome (Nakatsuji et al., 2012). Expressed in endothelial 
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cells, Sema4A inhibits vascular endothelial growth factor (VEGF)-mediated mi-
gration and proliferation of endothelial cells and thus angiogenesis by signaling 
through plexin D1 (Toyofuku et al., 2007). In the retina, Sema4A was reportedly 
required for the exosomal release of anti-apoptotic prosaposin, preventing the 
loss of retinal pigment epithelial cells induced by oxidative stress and regulated 
the transport of retinoid binding proteins (Toyofuku et al., 2012). Interestingly, no 
receptor was necessary for Sema4A to exert its effects: Instead, Sema4A was 
identified as a regulator of endosomal transport mechanisms. In addition to its 
role as a ligand, Sema4A has been described to act as a receptor to plexin B1 as 
well, increasing migratory behavior of several cancer cell lines (Sun et al., 2017). 
In familial colorectal cancer type X, a hereditary non-polyposis colorectal cancer, 
germline mutations of the SEMA4A gene were discovered to increase MAPK/Erk 
signaling (Schulz et al., 2014).  
Semaphorin 4B (Sema4B), initially named SemC, was originally discovered in the 
central nervous system (Püschel et al., 1995), although no functional role was 
assigned to it at that time. Later, an expression analysis found Sema4B, among 
others, to be expressed in the developing and regenerating olfactory epithelium 
(Williams-Hogarth et al., 2000). Like Sema4A, it has since been assigned a role 
in the immune system: Sema4B is expressed on T cells and inhibits basophil-
mediated immune responses (Nakagawa et al., 2011). In the kidney, Xia et al. 
discovered Sema4B to be expressed in tubular epithelial cells and identified 
plexin B2 as its receptor (Xia et al., 2015). They further found Sema4B, together 
with Sema4D and Sema4G, to be required for tubular epithelial repair upon is-
chemic injury. Some publications also linked Sema4B to lung cancer, in which it 
inhibits proliferation, tumor cell motility, and metastasis (Jian et al., 2014, 2015; 
Nagai et al., 2007).  
Semaphorin 4C (Sema4C) was first described to be expressed in the brain, kid-
ney, liver, heart, lung, and spleen of adult mice, although still named SemF at the 
time (Adams et al., 1996). Since then Sema4C has been found to be central in 
organ development: In the cerebellum, where it signals through plexin B2, 
Sema4C-deficient mice suffered exencephaly (Maier et al., 2011). In the kidney, 
Sema4C is required for ureteric branching (Perälä et al., 2011). Inflammatory hy-
persensitivity to pain mediated by peripheral sensory neurons also depended on 
Sema4C-plexin B2 signaling (Paldy et al., 2017). Sema4C is further a substrate 
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to γ-secretase, that mediates proteolytic cleavage of its extracellular domain 
(Hemming et al., 2009). In the immune system, Sema4C signals through plexin 
B2 to efficiently generate plasma cells (H. Yan et al., 2017). Additional roles have 
been described in cancer: In breast cancer models, Gurrapu et al. described 
Sema4C signaling through plexin B2 to be required to maintain proliferation in 
breast cancer cells (Gurrapu et al., 2018). In a separate publication, the same 
group reported that Sema4C also increased metastasis by reverse signaling, in 
which plexins B1 and B2 serve as ligands (Gurrapu et al., 2019). Similar functions 
were described by Smeester et al. in osteosarcomas, where Sema4C increased 
tumor growth (Smeester et al., 2020).  
Semaphorin 4D (Sema4D), also known as CD100, is expressed on cells of the 
immune and nervous system, osteoclasts, in the kidney, and on tumor-associated 
macrophages (TAMs) (Worzfeld & Offermanns, 2014). Like other class 4 sema-
phorins, it can be cleaved proteolytically (Xiaosong Wang et al., 2001). Under 
physiological conditions, Sema4D promotes angiogenesis through its receptor 
plexin B1 (Basile et al., 2006). As mentioned previously, Sema4B, Sema4D, and 
Sema4G facilitate renal tubular epithelial repair by concertedly signaling through 
plexins B1 and B2 (Xia et al., 2015). Furthermore, a study by Meehan et al. found 
all epithelial cells of the colon to be plexin B2-positive and intraepithelial γδ T 
lymphocytes in the colon to be Sema4D-positive. This signaling axis proved to be 
important, as Sema4D-knockout mice were more strongly affected by DSS-in-
duced colitis (Meehan et al., 2014). This phenotype was attributed to a loss of 
keratinocyte growth factor-1 (KGF1) production, an epithelial growth factor that 
was previously shown to be protective against colitis (Chen et al., 2002). In tu-
mors, Sema4D was generally found to promote disease progression: In Sema4D 
knockout mice, angiogenesis, growth and metastasis of xenograft tumors was 
reduced (Sierra et al., 2008). Consequently, an antibody blocking Sema4D is be-
ing investigated as a treatment option in tumors (e.g., drug VX15/2503; clinical 
trials.gov). A study by Ikeya et al. found the high expression levels of Sema4D 
and plexin B1 in colorectal cancers to predict worse survival in patients (Ikeya et 
al., 2016). Finally, Zhou et al. linked reverse signaling of plexin B1 through 




Semaphorin 4G (Sema4G) was initially identified by Li et al. and found to be ex-
pressed in the brain, kidney and liver of adult mice (H. Li et al., 1999). Little is 
known regarding its functions, outside of its role in cerebellar development, where 
Sema4G signals through plexin B2, albeit in a redundant manner with Sema4C 
(Maier et al., 2011). In the kidney Sema4G, together with Sema4B and Sema4D, 
is required for the repair of the tubular epithelium upon ischemic injury (Xia et al., 
2015). Few reports exist about the role of Sema4G in cancer: These studies cor-
relate low expression of Sema4G with improved clinical outcomes in glioma and 
colorectal cancer, although further studies will be needed to corroborate these 
findings (Xiaoliang Wang et al., 2008; Xiao et al., 2020). 
Beyond the class 4 semaphorins described above, semaphorins have additional 
functions in the intestine: Stromal fibroblasts have been shown to secrete class 
3 semaphorins, that support the growth of intestinal organoids by signaling 
through neuropilin receptors, demonstrating a role in intestinal epithelial homeo-
stasis (Karpus et al., 2019).  
Angiogenin (ANG) is a secreted ribonuclease, initially isolated from the superna-
tant of HT-29, a human adenocarcinoma cell line. In the same work, the authors 
identified its capability to induce angiogenesis, one of its core functions (Fett et 
al., 1985). Early studies revealed angiogenin mRNA to be predominantly ex-
pressed in the liver, but also in the small and large intestine of adult rats (Weiner 
et al., 1987). Beyond its role in angiogenesis, it fulfills a variety of other functions, 
including the regulation of hematopoietic stem cell growth and survival, neuro-
genesis and innate immunity (Goncalves et al., 2016; Hooper et al., 2003; S. Li 
& Hu, 2012; Subramanian & Feng, 2007). ANG serves as a ligand that undergoes 
receptor-mediated endocytosis and exerts its functions in a context-dependent 
manner. Under conditions favoring growth, ANG is translocated to the nucleus, 
where it serves as a transcription factor increasing ribosomal RNA (rRNA) ex-
pression (Moroianu & Riordan, 1994; Tsuji et al., 2005). In stressed cells, it lo-
cates to the cytoplasm and inhibits translation for most mRNA species, excluding 
those with strong internal ribosomal entry sites (IRES), which are usually present 
in transcripts of anti-apoptotic and pro-survival genes (Ivanov et al., 2011). ANG 
was recently described to signal through plexin B2 (W. Yu et al., 2017). The au-
thors demonstrate plexin B2 to be both required and sufficient to mediate its func-
tions, i.e., proliferation, phosphorylation of MAP and ERK, protection from 
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apoptosis, nuclear translocation of ANG, and the production of rRNA. Further-
more, W. Yu et al. found treatment with an antibody directed against the ANG 
binding site of plexin B2 to reduce the size and angiogenesis of xenograft tumors 
in mice. In another study, preventing ANG from translocating to the nucleus by 
neomycin treatment reduced the growth of xenograft tumors in mice (Yoshioka et 
al., 2006). ANG was reported to be expressed in most CRCs and high levels of 
ANG mRNA were associated with a poor prognosis (Etoh et al., 2000; D. Li et al., 
1994). In a study investigating colitis, ANG secreted by myeloid cells was found 
to be protective for intestinal epithelial cells (Bai et al., 2020). These findings high-
light a role in the intestine and a therapeutic potential of ANG inhibition in cancers 
and substitution in e.g., colitis. Finally, loss-of-function mutations have been ob-
served in some neurodegenerative diseases like amyotrophic lateral sclerosis or 
Parkinson’s disease (Greenway et al., 2006; M. A. van Es et al., 2011). 
 
1.2.2 Plexins 
Plexins are a family of membrane-bound receptors, subdivided into classes A 
through D, that interact with semaphorins and in the case of class 3 semaphorins 
with neuropilins as co-receptors (Janssen et al., 2012; Takahashi et al., 1999; 
Tamagnone et al., 1999; Winberg et al., 1998). Furthermore, the receptor tyrosine 
kinases MET and ERBB2 can serve as co-receptors with B-plexins (Giordano et 
al., 2002; Swiercz et al., 2004). Recent evidence further indicates, that plexins 
can act as ligands to semaphorins e.g., plexin B1 to Sema4A and plexins B1 and 
B2 to Sema4C (Gurrapu et al., 2019; Sun et al., 2017). Binding between plexins 
and semaphorins is mediated by an N-terminal, extracellular sema domain 
(Tamagnone et al., 1999). In their inactive state, plexins form autoinhibited mon-
omers through a closed formation of their intracellular C-terminus (He et al., 
2009). Upon binding of a semaphorin homodimer, two plexin monomers are 
brought into close proximity, leading to the activation of downstream signaling, 
most notably the intracellular GTPase-activating protein (GAP) domain, that acts 
on Rap proteins, which regulate important processes like proliferation, cellular 
junctions, and cell polarity (Gloerich & Bos, 2011; Y. Wang et al., 2013), and the 
RHO-GTPase-binding domain (RBD), that activates RhoA and RhoC (Figure 3) 
(Pascoe et al., 2015; Y. Wang et al., 2013).  
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Previous publications, as well as unpublished data from another doctoral candi-
date, Ivana Matković, showed the receptors plexin B1 and B2 to be highly ex-
pressed in the intestinal epithelium (Meehan et al., 2014; Xia et al., 2015). Con-
sequently, this thesis focuses on plexins B1 and B2. Both are activated by class 
4 semaphorins, specifically Sema4A and Sema4D in the case of plexin B1 and 
Sema4A, Sema4B, Sema4C, Sema4D, Sema4G, and ANG in the case of plexin 
B2, as summarized in previous publications (Worzfeld & Offermanns, 2014; Xia 
et al., 2015; W. Yu et al., 2017). Plexin B2 has been assigned a central role in 
the developing nervous system: In the cerebellum, plexin B2 is the receptor to 
Sema4C and Sema4G (Maier et al., 2011), and is needed for immature granule 
cell migration and proliferation (Deng et al., 2007; Friedel et al., 2007). In the 
kidney, plexin B2 is required for ureteric branching, making it an important regu-
lator of organ development (Perälä et al., 2011). Xia et al. later demonstrated, 
that plexin B1/B2 double-deficient mice displayed renal tubular epithelial defects, 
further supporting a role in the developing kidney. Upon ischemic injury, they fur-
ther showed plexin B2 to be essential for the repair of the renal tubular epithelium. 
Knockout mice suffered a loss of epithelial architecture, that was attributed to a 
failure to properly align the mitotic spindle of dividing cells (Xia et al., 2015), high-
lighting an important role in epithelial regulation. Plexin B2 is further expressed 
on keratinocytes and crucially involved in epidermal damage repair, as it activates 
γδ T cells through Sema4D and blocking this interaction delayed wound healing 
(Witherden et al., 2012) In the skin, plexins B1 and B2 were recently described 
to act as mechanosensors regulating stem cell divisions through homophilic in-
teractions (Jiang et al., 2020). In cancer, plexin B1 fills opposing roles, with its 
effect depending on genetic context and the type of tumor: For example in 
ERBB2-overexpressing breast tumors, low plexin B1 expression indicated a bet-
ter prognosis, while the opposite was true in ERBB2-negative breast cancer 
(Worzfeld et al., 2012). Plexin B2 promotes glioma invasion (Le et al., 2015), and 
the stemness of cancer stem cells in the prostate (S. Li et al., 2020). Furthermore, 
the angiogenin-plexin-B2 axis protects epithelial cells in the colon from colitis (Bai 




1.3 Use of the Cre-loxP system to study cell type-specific 
gene function in the intestine 
The Cre-loxP system was initially described in the P1 bacteriophage by Sternberg 
and Hamilton (Sternberg & Hamilton, 1981). It depends on two components, the 
Cre recombinase and a genetic locus flanked by loxP DNA motifs, often referred 
to as “floxed” (Sauer & Henderson, 1988). Once Cre is expressed and active, the 
floxed locus is excised by the recombinase. By now, the Cre-loxP system is fre-
quently used to generate transgenic mice, e.g., gene knockout animals, a useful 
tool in studying a wide variety of physiological and pathological processes (McLel-
lan et al., 2017). To obtain these transgenic animals, both Cre recombinase, as 
well as the floxed DNA loci must be integrated into the genome. This can be 
achieved through the injection of modified DNA templates into mouse oocytes, 
that then grow into the transgenic animals (Vintersten et al., 2008). In many cases 
either spatial or temporal control over the activity of Cre is desired. Gu et al. 
demonstrated that cell type-specific Cre activity can be achieved by tying its ex-
pression to the activity of a cell-type specific promoter (H. Gu et al., 1994), ena-
bling targeted, non-systemic knockouts. To provide temporal control over recom-
bination activity, Cre recombinase can be coupled to a mutated estrogen receptor 
(CreER), that leads to the sequestration of Cre from the nucleus (Hayashi & 
McMahon, 2002). To relocate the fused recombinase to the nucleus, the animals 
or cells are treated with tamoxifen, a process that might have undesirable influ-
ence on several biological processes and may only work partially. In addition, a 
certain level of unspecific activation of CreER might also occur. Therefore, con-
stitutive expression of Cre may be preferable in some experimental settings.  
To generate transgenic mouse lines expressing Cre in a controlled manner, ho-
mologous bacterial artificial chromosome (BAC) recombination can be used to 
integrate Cre into a section of genomic DNA at a specific location. Subsequently, 
the modified BACs are injected into mouse oocytes where they integrate into the 
genome and give rise to transgenic mice carrying the desired genetic modifica-
tion. Several mouse lines exist, that express Cre in the intestinal epithelium or 
one of its cell types, including an inducible Alpi-CreER mouse line, that expresses 
Cre in enterocytes upon treatment with tamoxifen (Tetteh et al., 2016). However, 
no constitutive Alpi-Cre mouse line has been described to date. Given the fast 
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turnover of the intestinal epithelium, conditional modification of the genome might 
not be sufficient, as modified cells are quickly lost from the epithelium, thus mask-
ing potential effects of the genetic modification. Consequently, constitutively ac-
tive, enterocyte-specific Cre mouse lines would be a useful tool in the study of 
intestinal epithelial dynamics. As part of this thesis, a bacterial artificial chromo-
some (BAC) was recombined to constitutively express Cre recombinase under 
the control of the enterocyte-specific Alpi promoter. The BAC was furthermore 
prepared for the injection into mouse oocytes with the goal of breeding a novel 
Alpi-Cre mouse line. Lastly, the expression of Cre in these mice was analyzed in 
collaboration with Josina Großmann as part of her bachelor thesis. 
 
1.3.1 Bacterial artificial chromosome recombination 
Bacterial artificial chromosomes (BACs) are a tool that originated from the Human 
Genome Project, during which the entire human genome was sequenced. Their 
main function was to make fragments of genomic DNA easier to maintain and 
manipulate. These fragments were integrated into plasmid backbones containing 
E. coli’s F factor, making it possible to amplify and maintain DNA sequences of 
up to 300 kb in E. coli (Shizuya et al., 1992). Utilizing these BACs, genomic DNA 
sequences can be modified by homologous or Red/ET recombination. This pro-
cess is mediated by the Redα/Redβ recombination proteins derived from the λ 
phage (Muyrers et al., 1999; Youming et al., 1998; D. Yu et al., 2000). The method 
can be used to insert, delete, or replace parts of genomic DNA in the BAC. Plas-
mids are employed to express the required recombination proteins in the BAC-
carrying bacteria. In addition, the desired insert is provided as a linear DNA mol-
ecule flanked by homology arms that correspond to the target site in the BAC. 
Efficient homologous recombination relies on the formation of double-strand-
breaks (DSBs) in the targeted DNA molecule, for which Redα/Redβ mediate DSB 
repair (Thaler et al., 1987). Redα serves as a 5’-3’ exonuclease, digesting one of 
the strands at the DSB, leaving a single-strand 3’ overhang, to which the DNA 
annealing protein Redβ attaches. It facilitates the alignment with the homology 
arm of the linear template DNA sequence, for which the 3’ overhang serves as a 
primer, thus allowing for the replication of the targeted DNA molecule together 
with the insert. For the experiments described here, the plasmids provided with 
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the Counter-Selection BAC Modification Kit (Gene Bridges) were used, namely 
pSC101-BAD-gbaATet or pRED/ET for short. This plasmid carries the redαβγ 
operon, coding the recombination proteins under the control of the L-arabinose-
inducible pBAD promoter (Guzman et al., 1995). The protein AraC is expressed 
from the same plasmid and in the absence of L-arabinose, forms dimers which 
inhibit transcription at the pBAD promoter and thus of the Redα/Redβ recombi-
nation proteins. As soon as L-arabinose is added, AraC binds it, the transcrip-
tional inhibition is lifted and the Redα/Redβ recombination proteins are ex-
pressed, making the bacteria recombination-competent. Another site-directed re-
combination method used here is the flippase-flippase recognition target (FLP-
FRT) recombination method, that functions similarly to Cre recombination (Buch-
holz, 1996). Once FLPase is expressed, it recognizes FRT sites, which direct its 
activity. Modified BACs can then be used to generate transgenic mouse lines and 
intestinal organoids (Schwank, Andersson-Rolf, et al., 2013).  
 
Figure 4 Schematic of BAC recombination steps. (A) pRED/ET-mediated homologous recombi-
nation of the Cre2 insert into the Alpi BAC. (B) FLPase-mediated removal of the ampicillin re-
sistance selection marker. 
In the experiments described in this thesis, Cre2-recombinase was integrated into 
the Alpi gene by homology-directed BAC recombination and FLP-FRT (Figure 4). 
The final FLPase-modified BAC was injected into mouse oocytes by 
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collaborators, generating a mouse line expressing the Cre2-recombinase under 
the control of the Alpi promoter (Vintersten et al., 2008). 
 
1.4 The intestinal organoid model 
Intestinal organoids are a primary three-dimensional (3D) cell culture model, 
closely resembling the intestinal epithelium. Single LGR5+ ISCs or intestinal 
crypts are isolated and seeded into a protein matrix where they grow into complex 
structures. They recapitulate the crypt-villus architecture and contain all epithelial 
cell types (Sato et al., 2009). In this manner they can not only be propagated for 
extended periods, but also cryopreserved and manipulated in different ways, 
making them a powerful tool in the study of the intestinal epithelium and its dis-
eases. Under the right culture conditions ISCs form small spheroids that are still 
largely homogeneous in their cell composition. After ca. 72 h of culture, cellular 
symmetry is broken by the formation of the first stem cell niche, consisting of both 
Paneth and LGR5+ ISCs (Serra et al., 2019). From there, organoids start to grow 
“buds”, that extend outwards, forming finger-like structures that recapitulate the 
intestinal crypt. The stem cell niche remains located at the outermost tip, while 
differentiated cells are located towards the central part of the organoid, mimicking 
the in vivo crypt-villus architecture elegantly. Intestinal organoids depend on 
niche factors that maintain its stem cell pool and promote proliferation. As the 
Wnt pathway is a core regulator of stemness in the intestine, its activation is cru-
cial. To that end, culture media typically contain the LGR5 ligand R-Spondin1, a 
positive regulator of Wnt signaling. While in mouse small intestinal organoids in-
trinsic production of Wnt ligand is sufficient, colonic cultures, as well as human 
intestinal organoids require exogenous Wnt as well. In addition, EGF is added as 
a general promoter of proliferation and important factor in the maintenance of the 
intestinal stem cell niche. Furthermore, BMP signaling is inhibited by Noggin, as 
it would otherwise increase differentiation of epithelial cells (Sato et al., 2013). As 
mentioned earlier, intestinal organoids are cultured in a protein matrix, very fre-
quently Matrigel (Corning) is used. This substrate is manufactured from proteins 
secreted by Engelbreth-Holm-Swarm mouse sarcoma cells. It is rich in laminin 
and collagen and provides a growth environment that closely imitates the basal 
lamina underlying the epithelium. While the medium components required for 
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organoid culture are well defined, the exact composition of extracellular matrices 
is still unclear as they are produced from cell cultures (Kleinman & Martin, 2005).  
Utilizing the organoid model, primary intestinal cells become accessible to ma-
nipulation by a wide variety of methods. Their gene expression can be modified 
by transfection, electroporation or viral transduction with plasmids and BACs (M. 
Fujii et al., 2015; Koo et al., 2012; Schwank, Andersson-Rolf, et al., 2013). These 
engineered organoids can then be studied extensively, characterizing e.g. 
changes in morphology, differentiation, or function. Some of these methods have 
already been used to model diseases like cystic fibrosis or intestinal cancer ex 
vivo, using patient-derived organoids in conjunction with genome modification 
methods like CRISPR-Cas9 (X. Li et al., 2014; Matano et al., 2015; Schwank, 
Koo, et al., 2013). As organoids can easily be treated with biologically active com-
pounds, patient-derived organoids have also been used for high-throughput drug 
screenings, providing invaluable information on the efficacy in the targeted tissue 
without having to rely on model organisms. This method bridges the gap between 
two-dimensional (2D) cell culture and e.g. PDTXs or the application of com-
pounds to an entire organism in drug development. Beyond that, patient-derived 
organoids have been demonstrated to model their parent tumor’s treatment re-
sponse, highlighting a useful role in the personalization of medical treatment 
(Vlachogiannis et al., 2018). As intestinal organoids only consist of epithelial cells, 
they do not recapitulate stromal interactions as e.g. PDTXs do. To fill this gap, 
organoids have been co-cultured e.g. with neurons and myofibroblasts 
(Bohórquez et al., 2015; Pastuła et al., 2016). While this approach may not fully 
replicate the situation in vivo, it does however enable the controlled introduction 
of stromal cells and thus focused studies of the role of certain stromal elements. 
To better characterize host-pathogen interactions, organoid co-cultures with mi-
crobial or viral pathogens have been established, allowing for the study of infec-
tious GI tract diseases as well (Dutta & Clevers, 2017). Furthermore, cells derived 
from organoids can be used in single-cell sequencing, providing highly detailed 
information about e.g. gene expression without the risk of stromal contamination 
of the samples. Like this, even rare cell types in the intestinal epithelium can be 
examined closely (Grün et al., 2015). One key aspect of intestinal epithelial func-
tion is the ability of ISCs to efficiently generate appropriately differentiated daugh-
ter cells, a process that can be modeled by organoids ex vivo.  
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2 Aim of the study 
This study aims to analyze the expression and function of Plexin-B ligands in the 




Single-use lab ware for general use and cell culture was obtained from Greiner 
Bio-One, Sarstedt, USA Scientific, and ibidi. Specifically required materials are 
listed below. 
3.1 Laboratory consumables 
Table 1 Laboratory consumables 
Material Manufacturer 
Austerlitz Insect Pins Minutiens Fine Science Tools 
Electroporation cuvettes, 1 mm Carl Roth 
Embedding Cassette Carl Roth 
Immedge hydrophobic barrier PAP pen Vector Laboratories 
Membrane filter, 0.025 µm pore size Millipore 
Superfrost Ultra Plus glass slides Thermo Scientific 
Vacuum Filter Filtropur V 25; 0.45 μm Sarstedt 
 
3.2 Technical equipment and devices 
Table 2 Technical equipment and devices 
Device Manufacturer 
Accu-Cut SRM Microtome Sakura 
Biofuge pico Heraeus 
Biofuge stratos Heraeus 
Centrifuge 5417R Eppendorf 
CFX Connect Real-Time PCR Detection System Biorad 
Cryostat Leica 
Electrophoresis Chamber University workshop 
Embedding Machine TES99 Medite 
FlexCycler2 Biometra 
Gel iX20 Imager Gel Documentation Intas Science Imaging 
Genova Bio Spectrophotometer Jenway 
Heracell 150 Heraeus 
Herasafe Heraeus 




Leica DM750 Light Microscope Leica 
Leica ICC50W Camera Leica 
Leica Thunder Imaging Microscope Leica 
Luminoskan Ascent Luminometer Thermo Scientific 
MaxQ4000 Thermo Scientific 
MicroPulser Electroporator Biorad 
NanoDrop 1000 PEQLAB 
S20 SevenEasy pH meter Mettler Toledo 
Sorvall RC 5B Plus DuPont 
Thermomixer compact Eppendorf 
Zeiss Axio Vert.A1 microscope Zeiss 
Zeiss Laser Scanning Microscope (LSM) 700 Zeiss 
 
3.3 Cell culture 




Advanced DMEM/F12 Thermo Fisher Scientific 
B27 supplement Thermo Fisher Scientific 
BES Sigma-Aldrich 
Bovine serum albumin (BSA) Sigma-Aldrich 
Dulbecco’s modified eagle medium (DMEM) Capricorn Scientific 
Epidermal Growth Factor (EGF) Promokine 
Fetal bovine serum (FBS) Gibco 
Fugene HD Promega 
Gastrin I Sigma-Aldrich 
Gentamicin/Amphotericin B, 100x Gibco 
GSK-3 Inhibitor XVI CHIR99021 Millipore 





N-2 supplement Thermo Fisher Scientific 
N-Acetylcysteine Sigma-Aldrich 
Penicillin-Streptomycin Capricorn Scientific 
Phosphate buffered saline (PBS) Capricorn Scientific 
Polybrene Sigma-Aldrich 





Stable Glutamine 200 mM Capricorn Scientific 
Trypsin-EDTA (0.05 %, 0.02 % in PBS) Capricorn Scientific 
Valproic acid Sigma-Aldrich 




Table 4 Chemicals 
Chemical Supplier 
Acetic acid, 96 % Carl Roth 
Agar, bacteriological Carl Roth 
Agar, NEEO ultra-quality Carl Roth 
Ampicillin sodium salt Carl Roth 
Chloramphenicol Carl Roth 
D-sorbitol Carl Roth 
Diethyl pyrocarbonate (DEPC) Sigma-Aldrich 
Dimethylformamide Sigma-Aldrich 
Dimethylsulfoxide (DMSO) Carl Roth 
Disodium phosphate Carl Roth 
Eosin 1 %, alcoholic Morphisto 




Ethidiumbromide Carl Roth 
Ethylene diamine tetraacetic acid disodium salt dihydrate 
(EDTA) 
Carl Roth 
Ethylene glycol tetraacetic acid (EGTA) Carl Roth 
Glucose Carl Roth 
Glutaraldehyde Carl Roth 
Glycerol, 86 % Carl Roth 
Hydrochloric acid Carl Roth 
Isopropyl alcohol Carl Roth 
Kanamycin Sigma-Aldrich 
L-arabinose Sigma-Aldrich 
Magnesium chloride (hexahydrate) Carl Roth 
Magnesium sulfate (heptahydrate) J. T. Baker 
Monopotassium phosphate Carl Roth 
Mounting Medium Pertex Histolab 
Nicotinamide Sigma-Aldrich 
NP-40 Alternative Millipore 
Paraffin, 50-52 °C Carl Roth 
Paraformaldehyde Sigma 
Phenol-chloroform-isoamyl alcohol (PCI) Carl Roth 
Potassium acetate Carl Roth 
Potassium chloride Carl Roth 
Potassium ferricyanide Carl Roth 
Potassium ferrocyanide Carl Roth 
Sepharose CL-4B Sigma-Aldrich 
Sodium acetate Carl Roth 
Sodium chloride Carl Roth 
Sodium deoxycholate Carl Roth 
Sodium dihydrogen phosphate Carl Roth 
Sodium dodecyl sulfate (SDS) Carl Roth 
Sodium hydrogen phosphate (heptahydrate) Carl Roth 






Sucrose Carl Roth 
Tetracycline Sigma-Aldrich 
Tris Carl Roth 
Triton X-100 Carl Roth 
Tryptone Carl Roth 
X-Gal Sigma-Aldrich 
Xylene Carl Roth 
Yeast extract Carl Roth 
 
3.5 Kits 
Table 5 Kits 
Kit Supplier 
Alexa Fluor 488 Tyramide Superboost kit,  
Streptavidin 
Thermo Fisher Scientific 
Avidin/Biotin Blocking Kit Vector 
Counter-Selection BAC Modification Kit Gene Bridges 
Direct-zol RNA MiniPrep kit Zymo Research 
Dual-Luciferase Reporter Assay Promega 
NucleoBond Xtra Midi Macherey-Nagel 
NucleoSpin Gel and PCR Clean-up Macherey-Nagel 
NucleoSpin Plasmid Macherey-Nagel 
RNAscope 2.5 HD Reagent Kit Brown ACD Bio 






Table 6 Bacterial strains 
Bacterial Strain Supplier 
DH10B E. coli BACPAC CHORI 
NEB-10 beta electrocompetent E. coli NEB 
 
3.7 PCR and cloning reagents 
Table 7 PCR and cloning reagents 
Reagent Supplier 
100x BSA NEB 
10x Taq buffer with KCl Thermo Scientific 
DNA ligase buffer, 10x Thermo Scientific 
dNTP mix, 10 mM Thermo Scientific 
GC buffer, 5x Thermo Scientific 
Gene Ruler 100 bp Plus DNA ladder Thermo Scientific 
Generuler 1 kb DNA ladder Thermo Scientific 
HF buffer, 5x Thermo Scientific 
Loading dye, 6x Thermo Scientific 
MgCl2; 25 mM Thermo Scientific 
Polynucleotide kinase buffer A, 10x Thermo Scientific 




Table 8 Enzymes 
Enzyme Supplier 
BamHI Thermo Scientific 
BcuI (SpeI) Thermo Scientific 
EcoRI Thermo Scientific 
HindIII Thermo Scientific 
NheI Thermo Scientific 




Phusion HS II polymerase Thermo Scientific 
SalI Thermo Scientific 
T4 Polynucleotide kinase Thermo Scientific 
T7 DNA ligase Thermo Scientific 
Taq DNA polymerase Thermo Scientific 
XhoI Thermo Scientific 
 
3.9 Plasmids 
Table 9 Plasmids 
Plasmid Insert 
LT3GEPIR (Fellmann et al., 2013)⁠ empty vector 
LT3GEPIR_mS4A_sh1 mSema4A shRNA 1 
LT3GEPIR_mS4A_sh4 mSema4A shRNA 1 
LT3GEPIR_mTTL_sh2 mTTL shRNA 2 
p706-FLP (Gene Bridges) FLPase 
pCS2 β-CateninS33A constitutive active β-Catenin mutant 
pGL4.10[luc2]_FOP10 (Promega) Firefly luciferase 
pGL4.10[luc2]_TOP10 (Promega) Firefly luciferase 
phCre2-ERT2.pA.FRTN1ampFRT Cre2-ERT2 
pMDG.2 Lentiviral envelope plasmid 
pRL-CMV Renilla luciferase 
pSC101-BAD-gbaATet (pRED/ET), 
(Gene Bridges) 
BAC recombination proteins 




3.10 Bacterial artificial chromosomes 
BACs were sourced from the BACPAC Resources Center  
(https://bacpacresources.org). 
Table 10 Bacterial artificial chromosomes 
Clone Name Description 
RP23-173D12 BAC spanning the murine Alpi gene 
RP23-173L11 BAC spanning the murine Alpi gene 
RP23-437G2 BAC spanning the murine Alpi gene 
RP23-49O20 BAC spanning the murine Alpi gene 
 
3.11 Oligonucleotides 
Table 11 PCR and sequencing primers 






















Table 12 RTqPCR primers 


































shRNA plasmid cloning inserts 
Targeting sequences are highlighted as bold text in the full oligo sequence. 






















































3.12 Primary antibodies 
Table 14 Primary antibodies 
Antibody Species Supplier, Cat. number Dilution 
anti-hLyz1 rabbit DAKO; A0099 1:400 
anti-mAngiogenin mouse abcam; 10600 1:400 
anti-mOlfm4 rabbit Cell signaling; 39141S 1:400 
anti-mSema4B sheep R&D; AF6239 1:200 
anti-mSema4D rat Invitrogen; 14-1001-82 1:400 
 
3.13 Secondary antibodies 
Table 15 Secondary antibodies 
Antibody Species Supplier, Cat. number Dilution 
anti-mouse AlexaFluor 555 goat Invitrogen; A28180 1:500 
anti-rabbit AlexaFluor 488 goat Invitrogen; A11034 1:400 
anti-rat AlexaFluor 488 goat Invitrogen; A11006 1:200 
anti-rat AlexaFluor 555 goat Invitrogen; A21434 1:200 
anti-sheep AlexaFluor 546 donkey Invitrogen; A21098 1:400 
 
3.14 smRNA FISH probes 
Table 16 smRNA FISH probes 
Target transcript Supplier Catalog Number 
mAng ACD Bio 463971 
mPlxnb1 ACD Bio 469241 
mSema4A ACD Bio 498371 
mSema4G ACD Bio 461391 
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3.15 Buffers and solutions 
3.15.1 Bacterial media 
Lysogeny broth (LB, bacterial medium) 
• 10 g/l Tryptone 
• 5 g/l yeast extract 
• 10 g/l sodium chloride 
 
LB agar (bacteriological plates) 
• 10 g/l Tryptone 
• 5 g/l yeast extract 
• 10 g/l sodium chloride 
• 15 g bacteriological agar per liter medium 
 
Super Optimal Broth (SOB, bacterial medium) 
• 20 g/l Tryptone 
• 5 g/l yeast extract 
• 0.6 g/l sodium chloride 
• 0.2 g/l potassium chloride 
The resulting solution is autoclaved 20 minutes at 121 °C. Before use, 20 mM 
Mg2+ is added by preparing a 1 M Mg2+ solution: Equal volumes of 1 M MgCl2 ∙ 
6H2O and 1 M MgSO4 ∙ 7H2O are mixed and 20 ml/l of the resulting solution are 
added to the SOB medium. 
 
Super Optimal Broth with catabolite repression (SOC, bacterial medium) 
SOC medium is prepared like SOB medium (see above) before 20 mM glucose 
is added to finalize the medium. 
 
Bacterial freezing medium 
• 65 % glycerol 
• 0.1 M magnesium sulfate 
• 20 mM Tris, pH 7.7  
36 
 
Bacterial antibiotic stocks 
Antibiotic stock solutions were protected from light and stored at -20 °C when 
stored for extended periods. Working aliquots were kept at 4 °C and in the dark 
to prevent degradation. 
Table 17 Bacterial antibiotic stock solutions 
Antibiotic Stock concentrations Solvent 
Ampicillin 100 mg/ml ddH2O 
Chloramphenicol 30 mg/ml 100 % ethanol 
Tetracycline 10 mg/ml 75 % ethanol 
Kanamycin 30 mg/ml ddH2O 
Streptomycin 50 mg/ml ddH2O 
 
3.15.2 Plasmid and BAC DNA 
Small alkaline quickies (DNA isolation) 
Resuspension buffer S1 
• 50 mM Tris, pH 8.0 
• 10 mM EDTA 
• 0.1 mg/ml RNase A 
 
Lysis buffer S2 
• 0.2 M NaOH 
• 1 % Sodium dodecyl sulfate 
 
Neutralization buffer S3 
• 3 M Potassium acetate 
• 96 % Acetic acid (Add until the solution’s pH value reaches 5.5) 
 
10x Annealing buffer 
• 1 M NaCl 
• 100 mM Tris (stock solution: pH 7.4)  
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Oocyte injection buffer 
• 10 mM Tris (stock solution: pH 7.5) 
• 0.1 mM EDTA (stock solution: pH 8.0) 
• 100 mM NaCl 
The solution was sterile filtered prior to use. 
 
3.15.3 lacZ reporter staining solutions 
Solution A 
• 0.2 M NaH2PO4 ∙ H2O 
 
Solution B 
• 0.2 M Na2HPO4 ∙ 7H2O 
 
Solution C 
115 ml of solution A are mixed with 385 ml solution B and filled to 1 l with H2O. 
 
Solution D 
1 liter of solution C is supplemented with 5 mM EGTA and 2 mM MgCl2. 
 
Fixation buffer 
200 ml of solution D are mixed with glutaraldehyde to a concentration of 0.2 %. 
 
Washing buffer 
800 ml of solution D are mixed with sodium deoxycholate to a final concentration 
of 0.01 % and NP-40 to a concentration of 0.02 %. 
 
Staining buffer 
200 ml of washing buffer are supplemented with potassium ferricyanide to 




3.15.4 Immunostaining and FISH solutions 
Permeabilization and blocking buffer 
• PBS 
• 0.1 % v/v Triton X-100 
• 5 % v/v horse serum 
 
Tris -buffered saline with Tween (TBST) 
• 6,05 % w/v Tris 
• 8,5 % w/v NaCl 
The solution’s pH was set to 7.5-7.6. Before use, 200 μl of Tween were added 
per 100 ml of buffer. 
 
3.15.5 Cell culture media and solutions 
3.15.5.1 Cell culture solutions 
2x BES-buffered saline (BBS) 
• 50 mM BES 
• 1.5 mM Na2HPO4 
• 280 mM NaCl 
The substances were dissolved in ddH2O, the pH was adjusted to 6.95 and sterile 
filtered. Aliquots were stored at 4 °C. 
 
Calcium chloride solution 
CaCl2 was dissolved in ddH2O to a concentration of 2 M and sterile filtered. 
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3.15.5.2 Cell culture media for the generation of conditioned media 
Table 18 Medium compositions used in conditioned media production 
Wnt3a-conditioned medium R-Spondin1-conditioned medium 
Basal growth medium 
• DMEM 
• 10 % v/v FBS 
• 1x Penicillin-Streptomycin 
Basal growth medium 
• DMEM 
• 10 % v/v FBS 
• 1x GlutaMAX 
• 1x Penicillin-Streptomycin 
Selection medium 
• Basal growth medium 
• 100 mg/ml Zeocin 
Conditioning medium 
• DMEM 
• 10 % v/v FBS 
• 1x Penicillin-Streptomycin 
Conditioning medium 
• Advanced DMEM/F12 
• 10 mM HEPES 
• 1x GlutaMAX 
Freezing medium 
• DMEM 
• 15 % v/v FBS 
• 10 %v/v DMSO 
 
3.15.6 Organoid culture media and solutions 
Crypt chelation solution (CCS) 
Chemicals are dissolved in H2O to make a 5x stock solution and stored at 4 °C: 
• 28 mM Na2HPO4 
• 40 mM KH2PO4 
• 480 mM NaCl 
• 8 mM KCl 
• 220 mM Sucrose 
• 274 mM D-sorbitol 
To obtain the working solution, the 5x stock was diluted in PBS and supplemented 





A 1 % w/v BSA solution in PBS was prepared as a 10x stock solution for the use 
in organoid culture. The working solution was prepared by diluting one volume of 
10x stock in nine volumes of PBS and adding 1x Penicillin-Streptomycin. 
 
Basal medium 
• Advanced DMEM/F12 
• 10 mM HEPES 
• 2 mM L-Glutamine 
• 1x Penicillin/Streptomycin 
 
Organoid freezing medium 
• Basal Medium 
• 10 % v/v FBS 
• 10 % v/v DMSO 
 
3.15.6.1 Human colonic organoid media 
Human colonic organoid medium 
3 ml basal medium were supplemented as follows: 
• 5 ml Wnt3a-conditioned medium 
• 2 ml R-Spondin1-conditioned medium 
• 1x B27 supplement 
• 10 nm Gastrin I 
• 1 mM N-Acetylcysteine 
• 2.5 μM PGE-2 
• 100 ng/ml rmNoggin 
• 50 ng/ml EGF 
• 100 ng/ml rhIGF-1 
• 50 ng/ml rhFGF-basic 




Human colonic cancer organoid medium 
8 ml basal medium were supplemented as follows: 
• 2 ml R-Spondin1-conditioned medium 
• 1x B27 supplement 
• 10 nm Gastrin I 
• 1 mM N-Acetylcysteine 
• 2.5 μM PGE-2 
• 100 ng/ml rmNoggin 
• 50 ng/ml EGF 
• 100 ng/ml rhIGF-1 
• 50 ng/ml rhFGF-basic 
• 500 nM A83-01 
 
3.15.6.2 Mouse organoid culture media 
Crypt culture medium 
9 ml Basal Medium were supplemented with the following components: 
• 1 ml R-Spondin1 conditioned medium 
• 1x N-2 supplement 
• 1x B27 supplement 
• 1 mM N-Acetylcysteine 
• 100 ng/ml rmNoggin 
• 50 ng/ml EGF 
• 1 mM Valproic acid 





4 ml Basal Medium were supplemented with the following components: 
• 5 ml Wnt3a conditioned medium 
• 1 ml R-Spondin1 conditioned medium 
• 1x N-2 supplement 
• 1x B27 supplement 
• 10 mM Nicotinamide 
• 1 mM N-Acetylcysteine 
• 100 ng/ml rmNoggin 
• 50 ng/ml EGF 
• 1 mM Valproic acid 
• 10 μM CHIR-99021 
 
Organoid infection medium 
To prepare medium for lentiviral transductions of murine intestinal organoids, 




4.1 Cell culture 
4.1.1 Mouse intestinal crypt isolation and culture 
Mice were sacrificed, the small intestine was removed and placed in a petri dish 
with PBS. Intestinal contents were flushed out with PBS by placing the proximal 
end over the opening of a single-use plastic Pasteur pipette and carefully press-
ing PBS through the intestine. The intestine was then opened longitudinally, 
washed with PBS and cut into ca. 3-5 mm long pieces. The tissue pieces were 
then washed in a 50 ml centrifuge tube containing 20 ml PBS by gently rocking 
the tube and replacing the PBS ca. 2-3 times. Dissociation of the tissue was done 
by incubating the tissue with 5 mM EDTA in PBS for 5 minutes on a rocking 
shaker. The tissue was picked up with a 25 ml pipette and the remaining liquid 
was discarded. The pieces were pipetted up and down ca. 10 times, placed back 
in the centrifuge tube and washed with ca. 20 ml PBS 2-3 times. EDTA treatment 
and PBS washes were repeated up to 4 times in total before crypts were released 
mechanically by vigorous shaking of the tube for 30 seconds. The tissue pieces 
were then allowed to settle and 10 ml of the supernatant containing the crypts 
were immediately transferred to a 15 ml centrifuge tube coated with BSA-PBS, 
followed by centrifugation for 5 minutes at 500 g. From here on, the samples were 
kept on ice whenever possible. The supernatant was removed, and the pellet was 
resuspended in an appropriate volume of BSA-PBS, depending on the pellet size. 
For the use in cell culture, the number of crypts per ml was then determined by 
placing 10 μl of crypt suspension on a microscopy slide and counting the number 
of intact crypts. The desired number of crypts was transferred to a 1.5 ml tube 
coated with BSA-PBS and resuspended in basal medium and centrifuged for 3 
minutes at 300 g. The supernatant was removed, and the pellet was resuspended 
in Matrigel. 25 μl crypt-Matrigel suspension was then placed as droplets into the 
wells of a prewarmed 48-well plate. Matrigel was polymerized by incubation in a 
humidified cell culture incubator at 37 °C and 5 % CO2 for 10 to 25 minutes. Cells 
isolated for normal cell culture received 250 μl of crypt culture medium (CCM) per 
well supplemented with ROCK inhibitor for the first 48 h of culture. All organoids 
were cultured in a humidified atmosphere at 37 °C and 5 % CO2. 
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4.1.2 Human intestinal crypt isolation and culture 
Human normal and tumor tissue from the intestine and colon was acquired in 
cooperation with the Department of Visceral, Thoracic and Vascular Surgery and 
the Department of Pathology of the University Clinic Gießen and Marburg as part 
of the study “Organoid-Kulturen des normalen Darmepithels und maligner 
Darmtumoren” with the patient’s consent. Resected human small intestine or co-
lon was sent to the Department of Pathology without prior fixation. Tissue re-
quired for diagnostic analysis in the Department of Pharmacology was taken by 
a pathologist before any tissue was taken for organoid cultures. Ca. 3 cm2 of nor-
mal mucosa were taken with a distance of at least 10 cm from pathological le-
sions. If possible, 1 cm2 of epithelial tumor tissue was cut. Both samples were 
placed in chilled PBS for transport on ice. Intestinal epithelial cells were isolated 
for the establishment of human intestinal organoid cultures following a protocol 
provided by the group of Kim Jensen (BRIC, Copenhagen). All steps were per-
formed on ice. The resected tissue was washed 3 times in PBS supplemented 
with 1x Gentamicin/Amphotericin B by light shaking in a 50 ml centrifuge tube. 
The buffer was removed, and the tissue placed in a petri dish. The tissue was 
subdivided for multiple applications: One piece of epithelial tissue was snap-fro-
zen for RNA-isolation, another piece was fixed in 0.2 % paraformaldehyde (PFA) 
for histological analysis. 10-15 pieces of ca. 1 mm2 were cut from the epithelial 
section of the sample and placed in a 15 ml centrifuge tube coated with 0.1 % 
BSA-PBS. Mucus and debris were removed by vigorous shaking. The tissue was 
transferred to a fresh 15 ml centrifuge tube with 2 ml of Crypt Chelation Solution 
(CCS) and incubated for 15 minutes on ice. To mechanically release the crypts 
from the tissue, 3-4 mm of a 1,000 μl pipette tip were cut off and the tissue was 
pipette dup and down ca. 20 times. The tissue pieces were settled by gravity, and 
the supernatant was pipetted into a fresh 15 ml centrifuge tube coated with 
BSA-PBS. Fresh CCS was pipetted on the tissue. The CCS incubation and me-
chanical release of crypts was repeated up to five times in total. The crypt sus-
pensions were immediately centrifuged for 3 minutes at 300 g and 4 °C and the 
supernatant removed. The pellet was resuspended in 1 ml BSA-PBS and kept on 
ice until all isolation samples were prepared this way. All samples were then cen-
trifuged for 3 minutes at 500 g and 4 °C, the supernatant was removed, and the 
45 
 
pellet resuspended in the appropriate amount of Matrigel. 25 μl crypt-Matrigel 
suspension was then placed as droplets into the wells of a prewarmed 48-well 
plate. Matrigel was polymerized by incubation in a humidified cell culture incuba-
tor at 37 °C and 5 % CO2 for 10 to 25 minutes. Cells isolated from normal tissue 
received 250 μl of human colonic organoid medium per well, cells isolated from 
tumor tissue received 250 μl of human colonic tumor medium per well. All culture 
media were supplemented with ROCK inhibitor for the first 48 h of culture. All 
organoids were cultured in a humidified atmosphere at 37 °C and 5 % CO2. 
 
4.1.3 Organoid passaging 
All steps were performed on ice. To passage both human and murine intestinal 
organoids, the culture medium was removed. 500 μl of ice-cold BSA-PBS was 
added to each well, Matrigel droplets were scraped off with a 1,000 μl pipette and 
pipetted up and down ca. 3-5 times to break down the Matrigel. The resulting 
suspensions of up to 5 wells were collected in 15 ml centrifuge tubes coated with 
BSA-PBS and centrifuged 3 minutes at 300 g. The supernatant was removed, 
and the pellet resuspended in 900 μl BSA-PBS. To break down the organoids 
mechanically, the suspension was pipetted up and down ca. 20 times with the 
pipette tip opening pressed against the bottom of the centrifuge tube. Another 
900 μl of BSA-PBS was used to wash down any cells stuck to the walls of the 
tube, followed by another centrifugation for 3 minutes at 300 g. BSA-PBS washes 
and mechanical breaking of the organoids was repeated ca. 2-4 times, but at 
least until all remaining Matrigel was removed from the cell pellets. The resulting 
cell pellet was resuspended in 2 ml of basal medium and centrifuged for 3 
minutes at 500 g. The supernatant was removed, and the pellet resuspended in 
the desired volume of Matrigel. Typical subcultivating ratios ranged from 1:2 to 
1:5. 25 μl per well of the cell-Matrigel suspension were then seeded into each 
well of a prewarmed 48-well plate. The Matrigel was polymerized by incubation 
in a humidified cell culture incubator at 37 °C and 5 % CO2 for 10 to 25 minutes. 
Cells received 250 μl of the appropriate culture medium per well supplemented 
with ROCK inhibitor for the first 48 h of culture. All organoids were cultured in a 
humidified atmosphere at 37 °C and 5 % CO2. 
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4.1.4 Organoid freezing and thawing 
For extended storage, organoids were frozen in liquid nitrogen as follows: 3 to 5 
days after the last passage the medium was removed from 2 wells of a 48-well 
cell culture plate. 500 μl of freshly prepared organoid freezing medium were 
added to each well, followed by mechanical disruption of the Matrigel using the 
tip of a 1,000 μl pipette. After pipetting the cells up and down ca. 5 times, the 
organoid suspension of both wells was pooled into a freezing vial and placed in 
a freezing container at -80 °C overnight. The next day the frozen organoids were 
transferred to liquid nitrogen storage. To thaw frozen organoids, one vial of frozen 
cells was placed in a water bath at 37 °C until the freezing medium was com-
pletely liquefied. The suspension was then immediately added dropwise to 5 ml 
of prewarmed basal medium in a 15 ml centrifuge tube. The cells were centri-
fuged for 3 minutes at 500 g. The supernatant was removed, and the pellet re-
suspended in the desired volume of Matrigel. 25 μl per well of the cell-Matrigel 
suspension were then seeded into each well of a prewarmed 48-well plate. The 
Matrigel was polymerized by incubation in a humidified cell culture incubator at 
37 °C and 5 % CO2 for 10 to 25 minutes. Cells received 250 μl of the appropriate 
culture medium per well supplemented with ROCK inhibitor for the first 48 h of 
culture. 
 
4.1.5 Lentiviral transduction of intestinal organoids 
For lentiviral infection of intestinal organoids, 9 days prior to the day of transduc-
tion one well of organoids was seeded and cultivated in CCM for each viral con-
struct that was going to be transduced. To generate the lentiviral particles, 5 days 
before the transduction date one 150 cm2 dish of human embryonic kidney 293T 
cells (HEK-293T) was seeded for each construct, followed by calcium phosphate 
transfection as follows: The construct that was to be transduced was mixed with 
the two packaging plasmids pMDG.2 and psPAX2 at a ratio of 1:2:2, usually 
11:22:22 μg for a 150 cm2 dish and the volume was adjusted to 1,012 μl with 
sterile H2O. 2x BBS was shaken vigorously and 1,125 μl were added to the plas-
mid mix, immediately followed by 113 μl of 2 M calcium chloride solution that was 
added dropwise. The final transfection mix was incubated 20 minutes at room 
temperature and then dripped onto the previously seeded dish of HEK-293T cells, 
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that were then incubated normally for 3 hours before the culture medium was 
exchanged. The cells were then incubated undisturbed until the lentiviral super-
natant was harvested for the infection. Two days prior to transduction, organoids 
were passaged 1:2 as described above and cultured in stimulation medium. To 
collect the first batch of lentivirus, the medium on the virus-producing HEK-293T 
cells was collected and replaced with fresh medium. The supernatant was centri-
fuged for 5 minutes at 1,000 g, sterile filtered using a 0.22 μm syringe filter and 
stored at 4 °C overnight. The following day, another batch of lentivirus was col-
lected following the same protocol, pooling both batches after sterile filtration. To 
concentrate the virus, the filtrate was centrifuged at 4 °C and 8,000 g overnight, 
usually ca. 14 hours. On the day of transduction, the supernatant of the viral fil-
trate was discarded, and the resulting pellet was resuspended in organoid infec-
tion medium. The stimulated organoids were collected and broken up as de-
scribed for passaging up to the last BSA-PBS wash. The cells were then washed 
with PBS and a single-cell suspension was prepared by incubating the cell pellet 
with AccuMAX for up to 10 minutes at room temperature, pipetting up and down 
every 2-3 minutes and inspecting the cells microscopically. To quench Accutase 
activity, 5 ml of basal medium were added to the cells, followed by centrifugation 
for 3 minutes at 1,000 g. After removing the supernatant, the cell pellet was re-
suspended in the desired volume of infection medium, usually 100 μl per original 
well of organoids. 100 μl of cell suspension were mixed with 250 μl of viral sus-
pension and placed in a well of a 48-well plate. The cells were then “spinoculated” 
for 60 minutes at 600 g in a plate centrifuge, followed by 6 hours of incubation in 
a cell culture incubator with a humidified atmosphere at 37 °C and 5 % CO2. The 
cells were then collected in BSA-PBS-coated 1.5 ml centrifuge tubes using 1 ml 
of BSA-PBS, centrifuged for 5 minutes at 1,000 g and seeded in Matrigel as de-
scribed for regular organoid culture. For 72 h after transduction, infection medium 
supplemented with 10 μM Y-27632 was used, followed by CCM with added anti-
biotics to select for transduced cells. 0.5 μg/ml puromycin or 1.5 μg/ml blasticidin 





4.1.6 Functional organoid experiments 
To investigate ISC function in knockout organoids, intestinal crypts of knockout 
and control animals were isolated as described in section 4.1.1. Crypts were 
counted prior to seeding and 400 intestinal crypts per well of a 48-well plate were 
seeded and cultivated for 5 days, changing medium every second day. For the 
morphological analysis, the plate was imaged using the Zeiss LSM 700 confocal 
microscope’s transmitted light photomultiplier (T-PMT) to obtain 2D-images of the 
entire wells. The number of organoids and their morphology was then analyzed 
using the OrganoSeg software as described in section 4.4.3. To investigate ISC 
function in knockdown organoids, inducible shRNA-expressing organoids were 
generated by lentiviral transduction as described in section 4.1.5. Organoids were 
prepared for seeding as detailed in section 4.1.3. 25 μl of cell-Matrigel suspen-
sion were seeded into each well of an ibidi 8-well μ-Slide and covered with me-
dium. Expression of the shRNA constructs was induced immediately by adding 
1 μg/ml doxycycline. Imaging experiments were performed as detailed in section 
4.4.2, once immediately after seeding and then every 24 h for up to 168 h. After 
concluding the imaging experiment, organoid RNA was harvested as detailed in 
section 4.2.9. 
 
4.1.7 Cultivation of cell lines 
All cell lines were cultured were cultured in a humidified atmosphere at 37 °C and 
5 % CO2. HA-R-Spondin1-Fc 293T cells were cultivated using DMEM medium 
containing 10 % v/v fetal bovine serum (FBS) and 1x Penicillin-Streptomycin. 
Cells were passaged every 2-3 days by removing the culture medium, washing 
the flask with PBS and incubating the cells with Trypsin-EDTA solution for 5 
minutes or until all cells detached. Culture medium was then added to quench 
trypsin activity, followed by splitting the cells in a 1:4 to 1:6 ratio. The appropriate 
volume of culture medium was added according to the culture flask’s size. Wnt3a-
L-cells were cultivated using DMEM medium containing 10 % v/v FBS and 1x 
Penicillin-Streptomycin. Cells were passaged every 2-3 days by removing the 
culture medium, washing the flask with PBS and incubating the cells with Trypsin-
EDTA solution for 5 minutes or until all cells detached. Culture medium was then 
added to quench trypsin activity, followed by splitting the cells in a 1:4 to 1:6 ratio. 
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The appropriate volume of culture medium was added according to the culture 
flask’s size. HEK-293T and CMT-93 were cultivated using DMEM medium con-
taining 10 % v/v and 1x Penicillin-Streptomycin. Cells were passaged every 2-3 
days by removing the culture medium, washing the flask with PBS and incubating 
the cells with Trypsin-EDTA solution for 5 minutes or until all cells detached. Cul-
ture medium was then added to quench trypsin activity, followed by splitting the 
cells in a 1:10 to 1:20 ratio. The appropriate volume of culture medium was added 
according to the culture flask’s size. 
 
4.1.7.1 Generation of R-Spondin1-conditioned medium 
R-Spondin1-conditioned medium for the culture of intestinal organoids was gen-
erated from HA-R-Spondin1-Fc 293T cells. HA-R-Spondin1-Fc 293T cells were 
thawed and expanded in basal growth medium, followed by selection for 5 days, 
ensuring the presence of the R-Spondin1 construct in all cells. The cells were 
passaged when they reached 80-90 % confluence and usually split at ratios of 
1:4 and 1:6, maintaining confluence of ca. 40-90 %. For R-Spondin1-condition-
ing, 3 T175 cell culture flasks were seeded with cells and expanded until they 
reached 80 % confluence. The culture medium was then changed to conditioning 
medium, followed by 7 days of culture without another medium change or pas-
saging of the cells. The medium was then collected and centrifuged for 15 
minutes at 3,000 g and 4 °C. The supernatant was passed through a 0.45 μm 
vacuum filter and divided into 5 ml aliquots in 15 ml centrifuge tubes for storage 
at -80 °C. 
 
4.1.7.2 Generation of Wnt3a-conditioned medium 
Wnt3a-conditioned medium for the culture of intestinal organoids was generated 
from Wnt3a-L-cells. Wnt3a-L-cells were thawed and expanded in basal growth 
medium, followed by selection for 5 days, ensuring the presence of the Wnt3a 
construct in all cells. The cells were passaged when they reached 80-90 % con-
fluence and usually split at ratios of 1:4 and 1:6, maintaining confluence of ca. 
40-90 %. For Wnt3a-conditioning, 3 T175 cell culture flasks were seeded with 
cells and expanded until they reached 80 % confluence. The culture medium was 
then changed to conditioning medium, followed by 7 days of culture without 
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another medium change or passaging of the cells. The medium was then col-
lected and centrifuged for 15 minutes at 3,000 g and 4 °C. The supernatant was 
passed through a 0.45 μm vacuum filter and divided into 5 ml aliquots in 15 ml 
centrifuge tubes for storage at -80 °C. 
 
4.2 Molecular biology techniques 
4.2.1 Plasmid cloning of shRNA constructs 
The lentiviral inducible shRNA expression plasmids were designed and cloned 
as follows: Sequences targeting the genes of interest were selected from the da-
tabase provided by the RNAi Consortium (TRC) and tested in shRNA-expressing 
pLKO1 plasmids available from Sigma-Aldrich’s Mission shRNA library. The tar-
geting sequence’s ability to reduce mRNA expression in CMT-93 cells was tested 
by transfection of the plasmids, RNA isolation and quantification of target gene 
mRNA levels using RTqPCR. The screening experiments up to this point were 
done in collaboration with Inga Shcheglova as part of her bachelor’s thesis. 
Generally, the two most effective sequences for each gene were selected for 
cloning into the lentiviral doxycycline-inducible shRNA expression plasmid 
LT3GEPIR (Fellmann et al., 2013). To that end, two oligonucleotides, the forward 
and reverse strand, were designed following the general structure displayed in 
Figure 5. 
 
Figure 5 Structure of oligonucleotides used in shRNA cloning. 
The full oligonucleotide sequences used for each target gene are listed in Table 
13. First, the complementary oligonucleotides were annealed. To that end, a 1:1 
mix of both oligonucleotides was prepared as detailed in Table 19. 
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Table 19 shRNA oligonucleotide annealing reaction 
Reagent Volume per reaction 
Forward strand oligo (10 μM) 11.25 μl 
Reverse strand oligo (10 μM) 11.25 μl 
10x Annealing buffer 2.5 μl 
 
The annealing mix was then placed in a water bath of ca. 1 liter at 95 °C and left 
to cool until it reached room temperature, followed by 1:400 dilution in 0.5x an-
nealing buffer. In parallel, the target vector was linearized using restriction digest 
with both XhoI and EcoRI. The reactions were set up as described in the table 
below and incubated for 1 hour at 37 °C. 
Table 20 Linearization reaction of LT3GEPIR for shRNA cloning 
Reagent Volume per reaction 
LT3GEPIR (1 μg/μl) 4 μl 
10x Tango buffer 8 μl 
XhoI 1 μl 
EcoRI 1 μl 
ddH2O to 40 μl 
 
The digest reactions were then separated using agarose gel electrophoresis and 
the plasmid backbone fragment was isolated by gel cleanup, utilizing the Ma-
cherey-Nagel NucleoSpin Gel and PCR Clean-up kit according to the manufac-
turer’s instructions. Subsequently, the reactions ligating the double-stranded oli-
gonucleotides into the linearized plasmid backbone were set up as described be-
low and incubated for 1 to 3 hours at room temperature. 
Table 21 shRNA oligonucleotide ligation reaction 
Reagent Volume per reaction 
Annealed oligonucleotide dilution 1 μl 
Linearized plasmid 1 μl (10-20 ng) 
10x Ligation buffer 1 μl 
T4 DNA ligase 1 μl 




Transformation of up to 5 μl of each ligation reaction was performed as described 
in 4.2.5. Single colonies were selected and screened for plasmid carrying the 
correct insert. To that end, each colony was used to inoculate a backup LB agar 
plate, a colony PCR reaction as described in 4.2.6 and a 1.5 ml LB overnight 
culture for plasmid isolation as described in 4.2.7. Isolated plasmid DNA under-
went restriction digests to confirm structural integrity of the DNA construct, as well 
as sequencing to confirm the sequence of the insert. Plasmids for which correct 
ligation could be confirmed were then used for further experiments. 
 
4.2.2 Recombination of bacterial artificial chromosomes 
4.2.2.1 Donor plasmid cloning 
To insert an ampicillin selectable Cre construct into a BAC containing the Alpi 
gene, first a donor plasmid was generated from phCre2-
ERT2.pA.FRTN1ampFRT. To that end, the present Cre2-ERT2 insert was re-
placed with a Cre2 insert. First, the Cre2-ERT2 insert was removed by restriction 
digest using HindIII and BamHI. Simultaneously, the new Cre2 insert was PCR-
amplified from phCre2-ERT2.pA.FRTN1ampFRT utilizing primers #145 and 
#146, that added a 5’ EcoRI restriction site and a 3’ STOP codon to the Cre2 
insert. Subsequent ligation of that insert yielded the desired plasmid 
phCre2.pA.FRTN1ampFRT. For the homologous recombination into the BAC, 
additional homology arms were added both 5’ and 3’ of the cassette that was to 
be inserted into the BAC. The homology arms were PCR-amplified using primers 
#149/150 (5’) and #151/152 (3’) from the target BAC. Both homology arms were 
inserted into the donor plasmid by restriction digest and subsequent ligation. 
EcoRI and HindIII were used for the 5’ homology arm, NheI for the 3’ homology 
arm. Colony PCRs and sequencing of all intermediate steps was done using pri-
mers #147/148. 
 
4.2.2.2 BAC recombination 
In short, insertion of the ampicillin selectable Cre2 construct was performed uti-
lizing Red/ET recombination. Bacteria containing the target BAC were made re-
combination-competent by transformation of pRED/ET. The intended insert was 
PCR-amplified from the previously cloned donor plasmid 
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phCre2.pA.FRTN1ampFRT, cleaned up after agarose gel separation and trans-
formed into the newly recombination-competent bacteria (Figure 6 A). After con-
firmation of successful recombination of the insert into the BAC, the ampicillin 
selection cassette was removed by FLPase recombination (Figure 6 B). 
 
Figure 6 Schematic of BAC recombination steps. (A) pRED/ET-mediated homologous recombi-
nation of the Cre2 insert into the Alpi BAC. (B) FLPase-mediated removal of the ampicillin re-
sistance selection marker. 
To that end, an expression plasmid containing FLPase was transformed into bac-
teria containing the BAC that was to be modified. Successful FLPase recombina-
tion was confirmed by both test digest and PCR and correctly modified BACs 
were injected into mouse oocytes. In detail, the following protocol was used: 
 
Transformation of pRED/ET into E. Coli 
To make the bacteria containing the BAC recombination-competent, they were 
transformed with the plasmid pRED/ET. To that end, the day before the transfor-
mation, the bacteria were spread on a LB agar plate containing streptomycin to 
ensure their sensitivity to the antibiotic. In addition, a pre-culture of 1 ml LB me-
dium with chloramphenicol was inoculated and incubated at 37 °C and 1,000 rpm 
in a shaking heat block overnight. The following day, three reaction tubes with 
1.4 ml of LB with chloramphenicol were inoculated with 30 μl of the preculture 
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and cultivated 2-3 h at 37 °C and 1,000 rpm in a shaking heat block, followed by 
centrifugation for 30 seconds at 11,000 rpm and 2 °C. All further steps were per-
formed on ice. The supernatant was discarded, and the resulting pellet was 
washed three times by resuspending the bacteria in autoclaved ddH2O and cen-
trifuging as before. After the last wash step, the supernatant was discarded by 
pouring off, leaving ca. 20-30 μl to remain in the reaction tube, in which the pellet 
of bacteria was resuspended by flicking the tube. 1 μl of 20 ng/μl pRED/ET was 
added to two of the three bacterial suspensions, which were subsequently trans-
ferred to electroporation cuvettes, followed by electroporation using the E. coli 1 
standard protocol of the Biorad Micropulser. The bacteria were washed out of the 
cuvettes with 1 ml of LB medium without antibiotics and transferred to 1.5 ml re-
action tubes. One of the cultures, that received the plasmid was cultured at 37 °C, 
the other together with the control culture without plasmid at 30 °C and 1,000 rpm 
for 70 minutes. 100 μl of each preculture were streaked on an LB agar plate con-
taining both chloramphenicol and tetracycline to select for the BAC and pRED/ET 
respectively, followed by overnight incubation at 30 °C protected from light. 
 
Insertion of the Cre2-AmpR cassette into the BAC 
The following day, a preculture of 1 ml LB medium with chloramphenicol and tet-
racycline was inoculated with pRED/ET-positive bacteria and incubated at 30 °C 
and 1,000 rpm in a shaking heat block overnight. Four 1.5 ml reaction tubes were 
prepared with 1.4 ml of LB medium with chloramphenicol and tetracycline and 
inoculated with 30 μl of overnight preculture, followed by incubation at 30 °C and 
1,000 rpm until optical density at 600 nm reached 0.3, usually for ca. 2 hours. 
Two tubes were then stimulated with 50 μl of 10 % L-arabinose solution, the other 
two were left unstimulated as controls and culture continued for another 45 to 60 
minutes at 37 °C and 1,000 rpm. Preparation of bacterial pellets for transfor-
mation was then performed by centrifugation for 30 seconds at 11,000 rpm and 
2 °C. All further steps were performed on ice. The supernatant was discarded, 
and the resulting pellet was washed three times by resuspending the bacteria in 
autoclaved ddH2O and centrifuging as before. After the last wash step, the su-
pernatant was discarded by pouring off, leaving ca. 20-30 μl to remain in the re-
action tube, in which the pellet of bacteria was resuspended by flicking the tube. 
2-3 μl of the previously PCR-amplified Cre2 insert (primers #149/152) were 
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added to one arabinose-stimulated and one unstimulated tube of bacteria. All 
bacteria were then electroporated as described above, followed by a preculture 
in 1 ml of LB without antibiotics for 70 minutes at 37 °C and 1,000 rpm. 100 μl of 
these cultures were streaked on an LB agar plate containing both chlorampheni-
col and ampicillin to select for the BAC and the insertion of the Cre2 cassette. 
Tetracycline was omitted from the agar so bacteria would lose the pRED/ET re-
combination plasmid. Correct recombination was verified by PCR of both recom-
bination sites (5’: primers #149b/168; 3’: #146/152b) and restriction digest (BcuI; 
XhoI) of the BAC that resulted from the homologous recombination. 
 
FLPase-mediated removal of the Cre2 insert’s ampicillin resistance 
For each BAC clone tested successfully for the insertion of the Cre2-AmpR insert 
the following preparations were made for their transformation with the p706-FLP 
recombination plasmid. An overnight preculture was inoculated with a single 
clone in a 1.5 ml reaction tube containing 1.4 ml of LB medium with chloramphen-
icol and ampicillin and cultured at 37 °C and 1,000 rpm. The following day, two 
1.5 ml reaction tubes with LB containing chloramphenicol and ampicillin were in-
oculated with 30 μl of the overnight preculture each and cultivated at 37 °C and 
1,000 rpm for 2-3 hours. Preparation of bacterial pellets for transformation was 
then performed by centrifugation for 30 seconds at 11,000 rpm and 2 °C. All fur-
ther steps were performed on ice. The supernatant was discarded, and the re-
sulting pellet was washed three times by resuspending the bacteria in autoclaved 
ddH2O and centrifuging as before. After the last wash step, the supernatant was 
discarded by pouring off, leaving ca. 20-30 μl to remain in the reaction tube, in 
which the pellet of bacteria was resuspended by flicking the tube. To one of the 
tubes, 2 μl of 20 ng/μl p706-FLP was added and both bacterial suspensions were 
electroporated as described above, followed by a preculture in 1 ml of LB without 
antibiotics for 70 minutes at 30 °C and 1,000 rpm. 100 μl of each bacterial culture 
was streaked on LB agar plates containing chloramphenicol and tetracycline and 
incubated protected from light at 30 °C overnight. Single tetracycline-resistant 
colonies were then selected for the induction of FLPase recombination. A 
preculture of 200 μl LB with chloramphenicol and tetracycline in a 1.5 ml reaction 
tube was inoculated with a single colony and cultivated for 2 hours at 30 °C and 
1,000 rpm. The resulting bacterial suspension was streaked on LB agar plates 
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with chloramphenicol but without tetracycline resulting in the loss of p706-FLP, 
and incubated overnight at 37 °C, which induces expression of the FLPase. On 
the following day, single colonies were used to inoculate an LB agar backup plate 
containing chloramphenicol, and 2 1.5 ml reaction tubes, one with LB containing 
only chloramphenicol, the second with LB containing chloramphenicol and ampi-
cillin, which were incubated overnight at 37 °C and 1,000 rpm. Clones were se-
lected for analysis if bacteria did not grow in the culture with ampicillin, indicating 
successful FLPase-mediated removal of the ampicillin resistance in the Cre2 in-
sert. Correct modification was confirmed by PCR of the recombination sites (5’: 
primers #149b/168; 3’: #146/152b) and restriction digest of BAC DNA (BcuI; 
XhoI). In addition, the entire insert was PCR-amplified (primers #149b/152b) and 
sent for sequencing (primers #149/152/169/170). 
 
4.2.2.3 Preparation of BAC DNA for oocyte injection 
BAC DNA for oocyte injection was obtained by growing out the bacteria overnight 
in an Erlenmeyer flask with 300 ml of LB medium with chloramphenicol. BAC 
DNA was then prepared as follows: Bacterial overnight cultures were centrifuged 
10 minutes at 5,000 rpm and 4 °C. The supernatant was discarded, and the re-
sulting pellet was resuspended, lysed and neutralized using 12 ml each of the 
respective Macherey-Nagel NucleoBond Xtra Midi kit buffers. The samples were 
centrifuged 15 minutes at 4,000 rpm and 4 °C and the supernatant transferred to 
a 15 ml centrifuge tube. 2 ml of phenol-chloroform-isoamyl alcohol (PCI) were 
then mixed with the sample, followed by centrifugation for 15 minutes at 
4,000 rpm and 4 °C. The supernatant was transferred to a new 15 ml centrifuge 
tube and precipitated with isopropyl alcohol and centrifuged for 60 minutes at 
4,000 rpm and 4 °C. After discarding the supernatant, the pellet was dissolved in 
1 ml 10 mM Tris and mixed with 20 ml chloroform. The solution was centrifuged 
for 15 minutes at 4,000 rpm and 4 °C, the aqueous phase transferred to a new 
reaction tube and again mixed with chloroform at a ratio of 1:1. The samples were 
centrifuged for 10 minutes at maximum speed and room temperature in a micro-
centrifuge. The aqueous phase was transferred to a new reaction tube again and 
precipitated with isopropyl alcohol as before. The supernatant was discarded, 
and the DNA pellet dissolved in 10 mM Tris solution. Prior to the oocyte injection 
of the DNA, the BAC’s structural integrity was confirmed by restriction digest, 
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PCRs and sequencing of the full insert as described before. A clone that gave 
positive results in all tests was selected and linearized by restriction digest, re-
moving the pBACe3.6 plasmid backbone: 
Table 22 BAC linearization reaction 
Reagent Volume per reaction 
BAC DNA (2.5 μg/μl) 50 μl 
10x Buffer O 50 μl 
100x BSA 5 μl 
100 mM Spermidine 12.5 μl 
NotI 20 μl 
ddH2O to 500 μl 
 
Samples were incubated overnight at 37 °C and the restriction enzyme was heat 
inactivated at 65 °C for 20 minutes. Separation of the resulting DNA fragments 
was done by Sepharose gel permeation chromatography. To construct the col-
umn, a sterile 5 ml cell culture pipette was used (Figure 7). The filter string from 
the top end of the pipette was removed, pulled apart and part of it was placed in 
the pipette’s tip. Sepharose was then resuspended in its original container and 
added in small steps to prevent air from getting trapped in the column until the 
pipette was almost filled. A 12 ml syringe without a plunger was then placed on 
top of the pipette and fixed to it using strips of Parafilm to serve as a buffer res-
ervoir. Whenever necessary, the flow of buffer through the column was stopped 
by closing the tip of the 5 ml pipette with a micropipette tip that had its tip closed 
by melting it shut. To equilibrate the stationary phase of the column, 30 ml of 
oocyte injection buffer were passed through the column over the course of ca. 5 
hours and 40 minutes. To load the BAC digest reaction onto the column, it was 
mixed with the appropriate volume of 6x loading dye, the buffer reservoir was 
temporarily removed, and the digest reaction was slowly pipetted on top of the 
Sepharose without disturbing it. The sample entered the Sepharose column be-
fore the buffer reservoir was replaced and 10 ml of oocyte injection buffer were 
added. Starting at that time point, 20 500 μl fractions were collected. To confirm 
complete linearization, and identify the fractions with the highest concentration, 
45 μl of each fraction were separated using agarose gel electrophoresis as de-
scribed for the diagnostic BAC restriction digests. The fractions showing the 
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highest band intensity at the appropriate size were selected for oocyte injection 
and handed over to collaborators at the Max-Planck Institute for Heart and Lung 
Research (Bad Nauheim), who performed the oocyte injection and mouse hus-
bandry. 
 
Figure 7 Sepharose-based gel permeation chromatography column. Schematic of the Sepharose 
column assembly used to separate the linearized BAC from its plasmid backbone; dimensions 
not to scale. 
4.2.3 Bacterial cultures 
Bacteria were cultured in LB or on LB agar plates at 37 °C where not indicated 
otherwise. Antibiotics working concentrations are indicated in Table 23. 
Table 23 Working concentrations of bacterial antibiotics 
Antibiotic Working concentrations 
Ampicillin 100 μg/ml 
Chloramphenicol 15 μg/ml 
Tetracycline 3 μg/ml 
Kanamycin 15 μg/ml 




4.2.4 Preparation of electrocompetent bacteria 
Bacteria from a previous preparation or a tube of bought bacteria were streaked 
on an LB agar plate using a three-phase streaking pattern (T-streak) and culti-
vated overnight at 37 °C. A single colony from this plate was used to inoculate a 
10 ml SOB preculture in an Erlenmeyer flask and incubated 16-18 h at 37 °C and 
200 rpm in a shaking incubator. Subsequently, 6 Erlenmeyer flasks containing 
200 ml of prewarmed SOB were inoculated with 2 drops of preculture each, fol-
lowed by incubation at 37 °C and 200 rpm. Optical density of the cultures was 
measured regularly at a wavelength of 600 nm until it reached 0.5-0.7. The bac-
terial cultures were then transferred to centrifuge cups and placed on ice for 15 
minutes followed by centrifugation for 10 minutes at 5,000 rpm and 4 °C. The 
supernatant was removed, and the resulting pellet was resuspended in 200 ml of 
10 % v/v glycerol dissolved in distilled water per cup. Centrifugation and resus-
pension in glycerol were repeated, followed by another centrifugation step. The 
supernatant was then poured off and the pellets were resuspended in the residual 
glycerol by pipetting up and down. Finally, the resulting bacteria suspension was 
aliquoted to 100 μl and stored at -80 °C. 
 
4.2.5 Electroporation of plasmid DNA into bacteria 
Electrocompetent bacteria were thawed on ice and 50 μl were aliquoted into 
1.5 ml reaction tubes for each transformation reaction. Up to 5 μl of any DNA 
solution were added to the bacteria and mixed by flicking the tube. The entire 
volume was then transferred to an electroporation cuvette and electroporated us-
ing the E. coli 1 protocol of the Biorad Micropulser. 1 ml LB medium without anti-
biotics was used to resuspend the bacteria and incubated for 1 hour at 37 °C and 
1,000 rpm on a shaking heat block. To obtain single colonies, 250 μl of this 
preculture were streaked on LB agar plates containing the appropriate antibiotic 
to select for the transformed DNA molecule and incubated overnight at 37 °C. 
 
4.2.6 Colony PCR 
To identify bacterial colonies that carry the desired DNA construct after plasmid 
cloning or BAC recombination, colony PCR was used. A PCR master mix was 
prepared using the volumes indicated in Table 24. 
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Table 24 Colony PCR master mix 
Reagent Volume per reaction 
10x Taq buffer with KCl 5 μl 
MgCl2 8 μl 
dNTPs; 10 mM 1 μl 
DMSO 1.5 μl 
Forward primer; 10 μM 1 μl 
Reverse primer; 10 μM 1 μl 
Taq DNA polymerase 0.2 μl 
ddH2O to 50 μl 
 
Each reaction was inoculated with a single bacterial colony by tapping the colony 
with a pipette tip and then suspending the bacteria in the mix by pipetting up and 
down. When further expansion of the bacteria was required, the same tip was 
used to inoculate a LB backup plate as well as a small LB overnight culture. The 
colony PCR reaction was run in a thermocycler with the protocol in Table 25. 
Table 25 Colony PCR protocol 
PCR step Temperature [°C] Duration [s]  
Initial denaturation 95 180  
Denaturation 95 30 
x30 Annealing [Ta = Tm - 5] 30 
Extension 72 [product length in kb * 60] 
Final extension 72 300  
Hold 4 ∞  
 
The resulting PCR products were separated using agarose gel electrophoresis to 
determine if a bacterial clone contained the desired construct. 
 
4.2.7 Plasmid and BAC DNA isolation 
Small alkaline quickies 
To isolate plasmid or BAC DNA from bacteria, overnight cultures of 2 ml LB in a 
2 ml reaction tube were inoculated with the desired bacterial clone and incubated 
at 37 °C on a shaking incubator. The following day, cultures were centrifuged at 
13,000 rpm for 5 minutes and the supernatant was removed. The bacterial pellet 
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was resuspended in 200 μl of buffer S1 by pulse vortexing. 200 μl of buffer S2 
were added to each reaction and mixed by inverting. 200 μl of buffer S3 were 
added and samples were incubated on ice for 5 minutes and centrifuged at 
13,000 rpm for 10 minutes. The supernatant was transferred to a fresh 1.5 ml 
reaction tube, 500 μl PCI were added and the samples were mixed by vigorous 
shaking for 30 seconds, followed by centrifugation at 13,000 rpm for 5 minutes. 
The supernatant was again transferred to a new 1.5 ml reaction tube and DNA 
was precipitated by addition of 500 μl of isopropyl alcohol. Samples were placed 
at -20 °C for 10 minutes, centrifuged at 13,000 rpm for 10 minutes and the super-
natant was removed. The resulting pellet was washed with 500 μl 70 % ethanol, 
air-dried and dissolved in ddH2O. 
 
4.2.8 Diagnostic restriction digests of BACs 
The structural integrity and sequence identity of BACs was tested using restriction 
digests of BAC DNA. For this, fragment sizes were predicted by in silico digest 
using the ApE software (Davis, 2020). The digest reactions were then set up as 
follows: 
Table 26 Diagnostic BAC digest 
Reagent Volume per reaction 
10x Enzyme buffer 5 μl 
Restriction enzyme 2 μl 
BAC DNA 35 μl 
ddH2O to 50 μl 
 
Samples were incubated for 1 hour at 37 °C, mixed with 6x loading dye and sep-
arated in an agarose gel at 4 °C and 45 V over 24 hours with images of the gel 
being taken at varying intervals to document smaller DNA fragments. If neces-
sary, the gel run was extended beyond 24 hours to also be able to better differ-




4.2.9 RNA isolation 
RNA-isolation of both 2D cell cultures and organoids was done by first removing 
the culture medium, washing the cells with PBS and adding the appropriate vol-
ume of TriFast to each well, e.g. 250 μl for each well in a 48-well plate. After 2 
minutes of incubation, the reagent was pipetted up and down to dissolve the cells 
and the resulting solution was collected in 1.5 ml reaction tubes. 50 μl of chloro-
form were added to each tube, the samples were shaken vigorously for 15 sec-
onds and incubated 10 minutes at room temperature. The samples were then 
centrifuged for 5 minutes at 12,000 g and the aqueous supernatant was trans-
ferred to a new 1,5 ml reaction tube and the remaining sample discarded. 125 μl 
of isopropyl alcohol were added to each sample, the tubes were inverted to mix 
the solution and chilled for 10 minutes at -20 °C, before precipitation by centrifu-
gation for 10 minutes at 4 °C and 12,000 g. The supernatant was discarded two 
wash steps were done as follows: 500 μl of 70 % ethanol were added to each 
tube, and the samples were centrifuged for 5 minutes at 12,000 g. The superna-
tant was discarded and after the second wash step the pellets were air-dried and 
dissolved in 20 μl of nuclease-free H2O. 
 
4.2.10 Real-time quantitative polymerase chain reaction 
Reverse transcription 
Following RNA isolation, reverse transcription was performed to yield cDNA for 
the use in RTqPCR. For this, the desired amount of RNA per sample was mixed 
with 1 μl of random hexamer primer, filled to 12.5 μl with nuclease-free H2O and 
incubated at 65 °C in a thermocycler for 5 minutes. The samples were then mixed 
with 7.5 μl of the following master mix: 
Table 27 Reverse transcription master mix 
Reagent Volume per reaction 
5x Reaction buffer for RT 4 μl 
Ribolock RNase inhibitor 0.5 μl 
dNTPs 2 μl 
Reverse transcriptase 1 μl 
 
Reverse transcription was done following the protocol in Table 28. 
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Table 28 Reverse transcription thermocycler protocol 
Temperature Duration [minutes] 
25 °C 10 
42 °C 60 
70 °C 10 
4 °C ∞ 
 
The finished cDNA samples were then diluted to a final concentration of 2 ng per 
μl sample and stored at -20 °C or used immediately for analysis in qPCR. 
 
Real-time quantitative PCR 
Real-Time quantitative PCR was performed by preparing a master mix for each 
primer pair to be used in the reactions according to Table 29. 
Table 29 RTqPCR master mix 
Reagent Volume per reaction 
SybrGreen 12.5 μl 
nuclease-free H2O 7 μl 
Primer mix, 10μM 0.5 μl 
 
20 μl of this master mix was distributed to each well of a 96-well PCR plate and 
mixed with 5 μl of diluted cDNA solution, containing 10 ng of cDNA per reaction. 
The RTqPCR was then run in a CFX Connect Real-Time PCR Detection System 
qPCR machine using the following protocol: 
Table 30 RTqPCR protocol 
PCR step Temperature [°C] Duration [s]  
Denaturation 95 300  
Denaturation 95 15 
x39 Annealing 58 30 
Extension 72 30 
Melting curve 65 to 95 in 0.5 increments 5 per step  
 
mRNA expression levels were calculated using the ΔΔCt method, normalizing to 




4.2.11 Dual-luciferase assay 
Reporter cell transfection and stimulation 
To determine Wnt pathway activation capability of the Wnt3a-conditioned and R-
Spondin1-conditioned media, a Dual Luciferase Assay was performed using the 
Dual-Luciferase Reporter Assay Kit by Promega. HEK-293T cells were trans-
fected for use as reporter cells in a 24-well plate, for which the following plasmid 
mixes were prepared in DMEM: 
Table 31 Plasmid mixes for dual-luciferase assay reporter cell transfection 
Plasmid mix Plasmid concentrations 
TOP • pGL4.10[luc2]_TOP10; 100 ng per well 
• pRL-CMV; 10 ng per well 
FOP • pGL4.10[luc2]_FOP10; 100 ng per well 
• pRL-CMV; 10 ng per well 
TOP β-Cat • pGL4.10[luc2]_TOP10; 100 ng per well 
• pCS2 β-CateninS33A; 50 ng per well 
• pRL-CMV; 10 ng per well 
FOP β-Cat • pGL4.10[luc2]_FOP10; 100 ng per well 
• pCS2 β-CateninS33A; 50 ng per well 
• pRL-CMV; 10 ng per well 
 
Additionally, 0.5 μl of Fugene HD transfection reagent per well were mixed with 
100 μl of DMEM per well. 100 μl per well of this mix were added to each plasmid 
mix, followed by 15 minutes of incubation at room temperature. In the meantime, 
HEK-293T cells were trypsinized and counted. 30,000 cells per well were then 
added to each of the plasmid mixes and the final volume of all mixes was adjusted 
to 0.5 ml per well by adding DMEM culture medium. The transfection mixes con-
taining the cells were then seeded into the wells of a 24-well cell culture plate and 
incubated in a humidified cell culture incubator at 37 °C and 5 % CO2. The fol-
lowing day, the cell culture medium was exchanged to stimulation medium, con-
sisting of a mix of regular DMEM cell culture medium and 10 % R-Spondin1- or 
50 % Wnt3a-conditioned medium generated previously. For each stimulation 
condition, 2 wells of the TOP-transfected cells, as well as 2 wells of the FOP-
transfected cells were treated with stimulation medium. As a positive control 
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condition, 2 wells of the TOP β-Cat-transfected cells, as well as 2 wells of the 
FOP β-Cat-transfected cells received regular culture medium mixed with non-
conditioned conditioning medium used in the generation of R-Spondin1 and 
Wnt3a-conditioned media. As a negative control, 2 wells of the TOP-transfected 
cells, as well as 2 wells of the FOP-transfected cells received regular culture me-
dium mixed with non-conditioned conditioning medium used in the generation of 
R-Spondin1 and Wnt3a-conditioned media. Stimulation was done for 24 hours in 
a humidified cell culture incubator at 37 °C and 5 % CO2. Cells were then washed 
with PBS and 100 μl of 1x passive lysis buffer prepared according to the manu-
facturer’s directions were pipetted into each well of the cell culture plate followed 
by 15 minutes of incubation at room temperature on an orbital shaker. Lysates 
were then transferred to 1.5 ml reaction tubes and cleared by centrifugation for 
30 seconds at maximum speed. The supernatants were transferred to new 1.5 ml 




The Luciferase assay reagent and Stop & Glo reagent were prepared according 
to the manufacturer’s instructions. 20 μl of each sample were pipetted into a well 
of an opaque, white 96-well plate. Before the measurement, 100 μl of luciferase 
assay reagent were added to all samples and firefly luciferase was measured 
immediately using the luminometer. To measure renilla luciferase activity, 100 μl 
of Stop & Glo reagent were added to each sample and renilla luciferase activity 
was recorded using the luminometer. Wnt pathway activation was quantified by 
first dividing firefly luciferase luminescence to renilla luciferase luminescence for 
each sample for both TOP and FOP wells and then subsequently dividing the 














4.3 Histological and immunohistochemical methods 
4.3.1 Swiss rolling of small Intestine and colon samples 
Mice were sacrificed and the small and large intestine removed as required for 
analysis. The organs were placed in a glass petri dish with a 15 cm diameter, of 
which the bottom was filled with clear silicon and covered with PBS to wash the 
tissue. The distal end of the intestines was pinned to the silicon using 0.2 mm 
diameter minutien pins and opened longitudinally from the proximal end following 
the line where the mesentery was attached, pinning the sides of the tissue to the 
silicon as well. Remaining blood and intestinal contents were washed away with 
PBS, before replacing it with either 0.2 % PFA if the tissue was to be cryosec-
tioned or 4 % PFA for paraffin sections. Fixation lasted 1 hour, and the opened 
intestines were then rolled onto toothpicks starting from the distal side of the or-
gan and rolling towards the proximal side with the luminal side of the organ facing 
the roll’s inside. The tissue was fixated with minutien pins to prevent it from un-
rolling and placed in embedding cassettes for further preparation for either cryo-
sectioning as described in 4.3.2 or paraffin embedding and sectioning as de-
scribed in 4.3.3. 
 
4.3.2 Preparation of cryosections 
Fixation and sample storage 
For the preparation of cryosections from tissue, the samples were first fixed in a 
0.2 % PFA-PBS solution at 4 °C overnight. PFA-PBS was replaced by 30 % w/v 
sucrose-PBS solution and the samples were incubated at 4 °C overnight. In a 
polystyrene box half filled with dry ice, a sheet of aluminum foil was placed. To 
freeze the samples, they were taken from the sucrose-PBS solution and placed 
on the aluminum foil until they were frozen solid. With a pair of tweezers, the 
tissue was carefully loosened from the foil and wrapped in Parafilm followed by a 
layer of aluminum foil for storage at -80 °C. 
 
Cryosectioning 
For the sectioning of the fixed and frozen tissue, the samples were placed in the 
cryotome for equilibration to the temperature at which the tissue was to be sec-
tioned. Using O.C.T. embedding medium, the tissue was frozen to the specimen 
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disc in the desired orientation. After the embedding medium was cured, 25 μm 
sections were cut from the sample and collected on a Superfrost Ultra Plus glass 
slide. The slides were dried at room temperature for 30 minutes and finally stored 
at -80 °C. 
 
4.3.3 Preparation of paraffin sections 
Fixation and embedding 
For paraffin embedding, the sample’s fixation was continued in 4 % PFA solution 
overnight at 4 °C followed by dehydration in alcohol solutions of ascending con-
centrations: 
• 70 % ethanol, 2 hours 
• 80 % ethanol, 2 hours 
• 95 % ethanol, 2 changes of 2 hours each 
• 100 % ethanol, 2 hours 
• 100 % ethanol, overnight 
• Ethanol-xylene 1:1, 1 hour 
• Xylene, 2 changes of 30 minutes each 
• Paraffin at 56 °C, 2 changes of 2 hours each 




Prior to sectioning paraffin-embedded tissue, the blocks were placed at -20 °C 
for one hour. In the meantime, the microtome was prepared and a water bath at 
40 °C was preheated. Generally, 5 μm sections were cut and placed in the water 
bath to stretch before being transferred to Superfrost Ultra Plus glass slides and 
dried on the water bath’s rim until the remaining water was evaporated. Samples 
prepared in this manner were either used for further experiments immediately or 




4.3.4 lacZ reporter staining 
To perform lacZ reporter stainings, cryosections of the tissue were prepared as 
described in 4.3.2. The samples were equilibrated to room temperature and any 
remaining condensation dried at room temperature. Subsequently, the slides 
were incubated in fixation buffer for 5 minutes. Three wash steps in wash buffer 
were performed, followed by staining buffer at 37 °C overnight in the dark. The 
following day, the samples were washed twice in PBS for 5 minutes per step. The 
slides were then counterstained with eosin for 5-10 seconds and differentiated in 
a 1 % v/v acetic acid solution. Next, they were dehydrated in alcohol solutions of 
ascending concentrations (70 %, 80 %, 95 %, 99 %; 2 minutes each) and two 
changes of xylene for 5 minutes each. Lastly, they were mounted using Pertex 
mounting medium. After curing of the mounting medium, the samples were ana-
lyzed using the Leica DM750 light microscope. 
 
4.3.5 Immunofluorescence staining 
Immunofluorescence (IF) stainings were done on previously prepared cryosec-
tions of tissue. To equilibrate the sections, the required number was taken out of 
the freezer and placed at room temperature until all condensation disappeared, 
usually for 20-30 minutes. The sections were then post-fixed for 10 minutes in 
4 % PFA at 4 °C. To quench the PFA, the samples were treated twice with 50 mM 
glycine in PBS for 5 minutes each and then washed with PBS for 5 minutes. Per-
meabilization and blocking were done for 30 minutes in PBS supplemented with 
0.1 % Triton X 100 and 5 % horse serum. For incubation with the primary anti-
body, the slides were placed in a wet chamber and the primary antibodies diluted 
in blocking solution were pipetted on top of the tissue sections. The samples were 
incubated overnight at 4 °C in the wet chamber. The following day, all sections 
were washed three times for 5 minutes with PBS, before the secondary antibod-
ies were added, diluted in blocking solution with added DAPI (1:5,000). The slides 
were incubated for 2 hours at room temperature in the dark before three final PBS 
washes for 5 minutes each. Lastly, the sections were mounted with DAKO fluo-
rescence mounting medium and allowed to cure before being stored at 4 °C or 




4.3.6 Single-molecule RNA fluorescence in situ hybridization 
Single-molecule RNA fluorescence in situ hybridization (smRNA FISH) is used to 
detect mRNA molecules on tissue sections by utilizing a mix of targeting probes, 
that bind to the transcript in a sequence-specific manner. Two of the probes need 
to bind adjacently on the transcript to increase specificity. Only then, the probes 
provide binding sites for a series of amplification reagents that serve to enhance 
signal intensity, making this method extremely sensitive. In the last step, chromo-
genic reactions produce either a Fast Red or 3,3’-Diaminobenzidine (DAB) pre-
cipitate. In addition, IF was used to stain the tissue for Lgr5, identifying stem cells 
in the intestinal crypt and allowing the quantification of a possible cell-type spe-
cific expression of mRNA transcripts. smRNA FISH was done using the 
RNAscope 2.5 HD assay BROWN or RED kits from ACD Bio. Generally, great 
care was taken to avoid the contamination of samples or reagents with RNases. 
Surfaces were regularly and thoroughly cleaned using 70 % v/v ethanol solution. 
All steps until finalization of the in situ hybridization were done using glass ware 
baked at 180 °C for 2 hours before use. Solutions were prepared using DEPC-
treated water. Prior to the preparation of 5 μm paraffin sections as described in 
4.3.3, the microtome and water bath were thoroughly cleaned using 70 % v/v 
ethanol. To remove excess paraffin, the slides were first baked for 1 hour at 60 °C 
and then treated with 2 changes of xylene for 5 minutes each, followed by 2 
changes of 100 % ethanol. Specimens were then air-dried for 5 minutes. Sample 
pretreatment was done as follows: Samples were incubated with Pretreat solution 
1 (H2O2) for 10 minutes at room temperature. After washing the slides in DEPC-
treated H2O twice, they were placed in a metal slide rack and boiled at 98-100 °C 
in Pretreat buffer 2 for 15 minutes. The slide rack was immediately transferred to 
DEPC-treated H2O, followed by 2 wash steps in DEPC-treated H2O and 1 step in 
100 % ethanol. The Slides were then air-dried for 5 minutes at room temperature. 
Using an Immedge hydrophobic barrier pen, the tissue on each slide was framed 
2-3 times and stored overnight in the dark at room temperature to let the frame 
dry. The following day, samples were treated with 50 μl protease for 30 minutes 
in a humidified rack at 40 °C using the HybEZ II oven. Protease was diluted 1:15 
in H2O if subsequent IF was planned. The slides were briefly washed twice in 
DEPC-treated water. Without letting the slides dry out, the samples were then 
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treated with the probe and amplification reagents. All incubation steps were per-
formed at 40 °C in a humidified atmosphere using the HybEZ II oven, followed by 
2 wash steps in 1x wash buffer for 2 minutes each. Generally, 1 drop of each 
reagent was used. Incubation times were as follows: 
• Probe: 2 hours 10 minutes 
• AMP1: 30 minutes 
• AMP2: 15 minutes 
• AMP3: 30 minutes 
• AMP4: 15 minutes 
Following AMP4 incubation and the described wash steps, samples were treated 
with AMP5 for 40 minutes at room temperature in the dark. After washing as be-
fore, 1 drop of AMP6 was applied for 15 minutes at room temperature, followed 
by another wash step. Signal detection differed between the kits used. When us-
ing the RNAscope 2.5 HD BROWN kit, solutions DAB-A and DAB-B were mixed 
1:1. After washing the samples in DEPC-treated H2O, 30 μl of the finalized DAB 
solution was pipetted onto each slide and the samples were incubated for 10 
minutes in the dark. When using the RNAscope 2.5 HD RED kit, the RED-B rea-
gent was diluted 1:60 in the RED-A reagent, pipetted onto the tissue sections and 
incubated for 10 minutes at room temperature in the humidified incubation cham-
ber. In both cases the tissue sections were briefly washed in distilled H2O twice 
after signal detection. The additional IF staining was done using the Alexa Fluor 
488 Tyramide Superboost kit, as well as the Avidin/Biotin Blocking kit. All steps 
were performed at room temperature, unless stated otherwise. The slides were 
placed in a wet chamber and the tissue was covered with Tris-buffered saline 
with Tween (TBST) to prevent samples from drying. Peroxidase activity was then 
blocked by incubation with 3 %H2O2 for 10 minutes in the dark, followed by two 
TBST wash steps. Using the Avidin/Biotin Blocking Kit reagents, samples were 
first incubated with 1 drop of avidin solution for 10 minutes in the dark, washed 
twice with TBST and then treated with 1 drop of biotin solution for 10 minutes in 
the dark and again washed twice with TBST. For blocking, samples were treated 
with 10 %v/v goat serum for 30 minutes. After that, primary antibodies were ap-
plied at the appropriate dilution in 10 % v/v goat serum and incubated overnight 
at 4 °C in a wet chamber. The next day the wet chamber was placed at room 
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temperature for 30 minutes prior to washing the tissue sections 4 times with 
TBST. The biotinylated secondary antibody was diluted in 10 % goat serum and 
added to each sample, followed by a 30-minute incubation in the wet chamber 
and 4 wash steps with TBST. The samples were then treated with Streptavidin-
HRP for 30 minutes and washed with TBST 4 times. Next, the Tyramide working 
solution was applied to the tissue, prepared from 100 μl of 1x Reaction buffer, 
1 μl H2O2, and 1 μl Tyramide Alexa Fluor 488 and incubated for 10 minutes in the 
dark. An equal volume of reaction stop reagent was then pipetted on each section 
and incubated for 1 minute, followed by 4 TBST washes. Lastly, the samples 
were stained with a 1:2,000 dilution of DAPI for 2 minutes in the dark, washed 4 
times with TBST and placed in distilled H2O for 5 minutes, before being mounted 
using DAKO fluorescence mounting medium. The mounting medium was cured 
for 10 minutes before analysis or storage at 4 °C. 
 
4.4 Imaging techniques 
4.4.1 Imaging and quantification of IF stainings and smRNA-FISH 
Immunostaining and single-molecule RNA in situ hybridizations were imaged us-
ing the Zeiss LSM 700 confocal microscope. Low magnification images were 
taken using a 20x objective, high magnification images using a 63x objective. The 
images were further processed in the Fiji distribution of ImageJ (Rueden et al., 
2017; Schindelin et al., 2012). In smRNA FISH experiments, cells positive for the 
mRNA species of interest were identified by either the red fluorescent precipitate 
or brown precipitate. To display the brown staining in a composite image with the 
fluorescence colors, T-PMT images of the section were taken to detect DAB pre-
cipitate, the brightness inverted, and assigned a false color. In both cases cell 
type-specificity for ISCs and Paneth cells was determined by IF co-staining for 
OLFM4. Starting at the crypt bottom, cells were identified as ISCs when they were 
OLFM4+ and as Paneth cells when they were OLFM4-. Based on the presence 
of precipitate, they were then counted as either FISH+ when precipitate was pre-




4.4.2 Live cell imaging of intestinal organoids 
For live cell imaging of intestinal organoids, the Leica Thunder Imaging Micro-
scope was used. Organoids were prepared following the protocol for passaging 
(4.1.3). 25 μl of the cell-Matrigel suspension were seeded into ibidi 8-well μ-Slides 
and covered with the appropriate medium. The slide was placed in the micro-
scope’s incubation chamber at 37 °C and 5 % CO2 for the duration of the imaging 
experiment. For morphological analysis, imaging was done using a 5x objective, 
recording a tile scan consisting of 3 by 3 z-stacks for each well covering the entire 
matrix drop. Z-stacks were transformed into 2D images using the Leica Applica-
tion Suite X (LAS X) software package’s extended depth of field (EDOF) function-
ality. 
 
4.4.3 Computational analysis of organoid images 
The images were further processed in the Fiji distribution ⁠ of ImageJ (Rueden et 
al., 2017; Schindelin et al., 2012). The 3x3 EDOF projections of each well were 
merged into a single image, using the Grid/Collection stitching plugin, and saved 
in the JPEG format (Preibisch et al., 2009). They were then imported into Orga-
noSeg (Borten et al., 2018), and organoid separation was generally done using 
the following slider settings: 
Threshold: 0.75 
Window size: 250 
Size threshold: 750 
Organoid metrics were exported and analyzed structures were visually inspected 
in OrganoSeg to confirm proper recognition of organoids and exclusion of e.g. 
cell debris. The data of any structure that was not an organoid, was removed from 
the exported data set prior to statistical analysis. 
 
4.4.4 Statistical analysis of imaging data 
4.4.4.1 Quantification of cell type-specific ligand expression in smRNA-
FISH images 
To quantify cell type-specific mRNA expression in Paneth and stem cells, high 
magnification images of small intestinal smRNA-FISH samples were analyzed. 
Starting from the crypt bottom, OLFM4 positive stem cells and OLFM4 negative 
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Paneth cells were identified and classified into FISH-positive and FISH-negative 
cells. From the obtained values, the percentage of cells positive and negative for 
the respective mRNA was calculated for both cell types. 
 
4.4.4.2 Statistical analysis of morphological organoid metrics obtained 
with OrganoSeg 
Morphological data obtained from organoid imaging experiments was analyzed 
by 2-way ANOVA using GraphPad Prism. 
 
4.5 Single cell RNA sequencing data and analysis 
Single cell RNA (scRNA) sequencing data published by Parikh et al. was ac-
cessed under the GEO accession number GSE116222 (Parikh et al., 2019). The 
data of healthy human colon cells from this data set was analyzed by Mario Looso 




5.1 Expression analysis of semaphorins and plexins in the 
intestinal epithelium 
To investigate the role of semaphorin-plexin signaling in the intestinal epithelium, 
first a systematic analysis of ligand expression was conducted. To that end, lacZ 
reporter stainings were used to analyze the expression of Sema4A, Sema4B, 
Sema4C and Ang. IF stainings were utilized to characterize expression of 
Sema4B and Sema4D. The expression patterns of Sema4A, Sema4G, Ang, and 
PlxnB1 transcripts, as well as potential cell type-specificity in the intestinal crypt 
were investigated by smRNA FISH paired with IF for the stem cell marker 
OLFM4-. Finally, scRNA sequencing data of healthy human colonic epithelium, 
previously published by Parikh et al., was analyzed for the expression of class 4 
semaphorins and plexins B1 and B2 (Parikh et al., 2019). 
 
5.1.1 Sema4A, 4B, 4C and angiogenin are expressed in the intestinal 
epithelium 
The expression of Sema4A, Sema4B, Sema4C and Ang in the small and large 
intestine was analyzed in lacZ reporter mice (Figure 8 and Figure 9 respectively). 
In these mice, a lacZ cassette was integrated into the genome under the control 
of the gene of interest’s promoter (Schmidt et al., 1998). The cassette contains 
the E. coli gene lacZ, encoding beta-galactosidase which is expressed once the 
promoter becomes active. Thus, beta-galactosidase activity marks cells, in which 
the promoter is active. Tissue sections were then stained by lacZ staining, during 
which beta-galactosidase enzymatically cleaves X-gal, ultimately producing 5,5'-
dibromo-4,4'-dichloro-indigo, an insoluble blue dye, highlighting promoter activity. 
Sema4D and Sema4G could not be characterized in this manner, since mice with 




Figure 8 lacZ reporter stainings reveal ligand expression patterns in the small intestine. lacZ re-
porter stainings of small intestinal cryosections (A) from wt control mice and (B) sema4a+/lacZ, 
sema4b+/lacZ, sema4c+/lacZ and ang+/lacZ transgenic mice reporter mice expressing beta-galacto-
sidase. wt: wild type. 
In the small intestine, the wild type (wt) control stainings revealed single spots of 
lacZ staining in the crypt bottom (Figure 8 A), representing background staining. 
The Sema4A reporter mice displayed a similar pattern in the crypt, but in addition, 
single epithelial cells in the lower part of the villi also showed weak staining. Ex-
pression in the Sema4B reporters was prominent in most of the epithelium but 
was weakest in the crypts. In the Sema4C reporter animals, lacZ staining in the 
crypts was roughly equivalent to the wt controls. Additionally, some stromal cells 
between crypts and villi were stained. In the Ang lacZ reporter stainings, some 
cells in the crypts were strongly stained, while others showed little or no staining. 




Figure 9 lacZ reporter stainings reveal ligand expression patterns in the large intestine. lacZ re-
porter stainings of colonic cryosections (A) from wt control mice and (B) sema4a+/lacZ, 
sema4b+/lacZ, sema4c+/lacZ and ang+/lacZ transgenic mice reporter mice expressing beta-galacto-
sidase. wt: wild type. 
In the colon, no lacZ staining was detected in wt control samples (Figure 9 A). In 
the proximal colon of Sema4A reporter mice, few crypts were stained (Figure 9 
B, top panel), but became more frequent in the distal large intestine. Generally, 
reporter expression was strongest in the middle of the crypts. Expression of the 
Sema4B reporter was high in the apical epithelium, while staining intensity de-
creased towards the crypt base. Sema4C reporter expression was low in the 
proximal colon and appeared mostly in luminal subepithelial cells. Towards the 
distal colon, this luminal staining diminished and only single stromal cells near 
the crypt were lacZ positive. Like in the small intestine, Ang reporter mice showed 
high expression in the crypt base and intensity decreased towards the luminal 
epithelium, where only single cells were stained. 
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5.1.2 Sema4B and 4D display distinct expression patterns 
Next, the expression of Sema4B and Sema4D was analyzed by immunofluores-
cence (IF) staining (Figure 10). For the remaining ligands, no specific antibodies 
suitable for IF staining were available. 
 
Figure 10 Immunofluorescence stainings of Sema4B and Sema4D. Cryosections of small and 
large intestine were immunostained for (A) Sema4B and (B) Sema4D. Nuclear counterstaining: 
DAPI. Scale bar: Low magnification 50 μm, high magnification 20 μm. Sema4B: Semaphorin 4B, 
Sema4D: Semaphorin 4D. 
Sema4B in the small intestine was most strongly detectable in the epithelium of 
the villi (Figure 10 A, top panels). High magnification of the crypt domain revealed 
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no expression in the crypt bottom and only very weak expression in the TA zone. 
In the murine colon, Sema4B was expressed in the entire epithelium with no dis-
cernible difference in intensity. Sema4D on the other hand showed overall weak 
expression but was detectable in the crypt bottom of the small intestine. No cell 
type-specificity for either stem or Paneth cells was observed based on cellular 
morphology. In the colon, Sema4D expression was restricted to singular stromal 
cells. 
 
5.1.3 Sema4A, 4G and angiogenin expression partially overlaps in 
the intestine 
Expression of Sema4A, Sema4G and Ang mRNA was analyzed by single-mole-
cule mRNA fluorescence in situ hybridization (smRNA FISH) paired with IF stain-
ing for the stem cell marker OLFM4. The RNAscope 2.5 HD kit (ACD Bio) was 
used. This method detects single mRNA molecules on tissue sections by utilizing 
a mix of targeting probes, that hybridize to the transcript in a sequence-specific 
manner. Two probes need to bind adjacently on the transcript to increase speci-
ficity. Only then, the probes provide binding sites for a series of amplification re-
agents that serve to enhance signal intensity, making this method extremely sen-
sitive. In the last step, chromogenic reactions produce either a Fast Red or 3,3’-
Diaminobenzidine (DAB) precipitate that indicates the presence of the transcript. 
In addition, IF was used to stain the same tissue for OLFM4, identifying intestinal 
stem cells in the crypt and thus enabling the quantification of cell-type specific 




Figure 11 Semaphorin 4A is widely expressed in both small and large intestine. smRNA FISH of 
Sema4A with nuclear counterstaining (DAPI) on (A) SI sections with additional IF of OLFM4 (stem 
cells) and (B) colon sections. (C) Quantification of Sema4a+ stem and Paneth cells of the SI crypt. 
Scale bar: Low magnification 50 μm, high magnification 20 μm. 
In the small intestine, Sema4A expression was detectable in the entire crypts and 
villi (Figure 11 A and B). Using a higher magnification, the crypt bottom was an-
alyzed for potential cell type-specific expression of Sema4A in the crypt base. 
Both OLFM4+ stem cells and the interspersed Paneth cells were frequently pos-
itive for Sema4A. Quantification revealed a rate of ca. 60 % Sema4A-positive 
cells without a discernible difference between the two cell types (Figure 11 C). In 
the colon, expression was similarly widespread, but the signal was strongest in 




Figure 12 Semaphorin 4G is expressed in the TA zone. smRNA FISH of Sema4G with nuclear 
counterstaining (DAPI) on (A) SI sections with additional IF of OLFM4 (stem cells) and (B) colon 
sections. (C) Quantification of Sema4g+ stem and Paneth cells of the SI crypt. Scale bar: Low 
magnification 50 μm, high magnification 20 μm. Brown precipitate was used for smRNA FISH and 
false colors were assigned as described in section 4.4.1. 
Sema4G was expressed in both small and large intestinal epithelium (Figure 12 
A and B). In the small intestine, the TA zone expressed Sema4G most strongly 
while the crypt bottoms and villi showed low expression and no expression, re-
spectively. Quantification of cell type-specificity showed ca. 75 % of stem cells to 
be positive for Sema4G, although expression in these cells was relatively low. 
Paneth cells were less frequently positive for Sema4G. The large intestine’s ex-
pression pattern was similar with precipitate being located mostly in the middle of 





Figure 13 Angiogenin is expressed weakly, but widespread. smRNA FISH of Ang with nuclear 
counterstaining (DAPI) on (A) SI sections with additional IF of OLFM4 (stem cells) and (B) colon 
sections. (C) Quantification of Ang+ stem and Paneth cells of the SI crypt. Scale bar: Low mag-
nification 50 μm, high magnification 20 μm. 
Ang expression was relatively low in the small intestine, although single Ang-
positive cells were observable along the entire villus. Expression was strongest 
in the TA zone and crypt bottom (Figure 13 A). Quantification of potential cell 
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type-specificity in the crypt base showed ca. 40 % of OLFM4+ ISCs and ca. 60 % 
of OLFM4- cells to be positive for angiogenin. smRNA FISH with a staining for 
the Paneth cell marker LYZ1 was performed and subjected to the same quantifi-
cation, which confirmed the initial finding, with 60 % of LYZ1+ Paneth cells and 
ca. 40 % of LYZ1- cells positive for angiogenin. In the colon the expression pat-
tern was strikingly different with most Ang-expressing cells being located at the 
luminal side of the epithelium and only few Ang-positive cells towards the crypt 
bottom. 
 
5.1.4 Plexin B1 is expressed in the entire intestinal epithelium 
Plexin B1 is a known receptor to class 4 semaphorins. Thus, smRNA FISH was 
used to characterize Plxnb1 mRNA expression patterns in the intestinal epithe-
lium, as well as possible cell-type specificity in the intestinal crypt. In the small 
intestine, Plxnb1 was expressed in the entire epithelium at comparable levels, 
without apparent specificity for any cell type (Figure 14 A). When focusing on the 
stem cell niche, both OLFM4+ and OLFM4- cells expressed Plxnb1 at similar 
rates, ca. 55 % of cells were positive for PlxnB1 (Figure 14 C). Like in the small 





Figure 14 Plexin B1 is widely expressed in both small and large intestine. smRNA FISH of Plxnb1 
with nuclear counterstaining (DAPI) of (A) SI sections with additional IF of OLFM4 (stem cells) 
and (B) colon sections. (C) Quantification of Plxnb1+ stem and Paneth cells of the SI crypt. Scale 
bar: Low magnification 50 μm, high magnification 20 μm. 
 
5.1.5 scRNA sequencing of human intestinal epithelial cells confirms 
expression analysis in mouse tissues 
To transfer the findings from the mouse intestine to human cells, a single cell 
sequencing data set of healthy human colonic epithelial cells published by Parikh 
et al. (GEO accession number GSE116222) was analyzed by Mario Looso (Max-
Planck Institute, Bad Nauheim) (Parikh et al., 2019). Single cell data was clus-
tered by similarity in gene expression. To identify which cluster represents which 




Figure 15 scRNA sequencing of human colonic epithelial cells reveal lineage-specific clusters. 
Clustering analysis of single-cell RNA sequencing data from human colonic epithelial cells. (A) 
Color-coded clusters grouped by similar expression patterns. Cell type markers identify lineage 
clusters: (B) stem cells (OLFM4), (C) EEC (REG4) and goblet cells (MUC2) of the secretory 
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lineage, (D) enterocytes (HES1). Visualization of data by Mario Looso (MPI, Bad Nauheim). Orig-
inal sequencing data (GSE116222) from (Parikh et al., 2019) 
Using the expression of OLFM4, cluster 1 was identified to most likely represent 
stem or early progenitor cells (Figure 15 B). REG4 and MUC2 are expressed in 
enteroendocrine and goblet cells respectively and thus mark cells of the secretory 
lineage. They were most strongly expressed in cluster 3 (Figure 15 C). Entero-
cytes are the most abundant epithelial cell type and marked by the expression of 
HES1, which was present in most clusters, but predominantly in clusters 1, 2 and 
4 through 6. (Figure 15 D). In summary, the top right cluster 2 likely represents 
stem cells, cluster 3 towards the top left represents the secretory lineage, and 
clusters 2 and 4 through 6 the absorptive lineage. 
After identifying lineage clusters, the mRNA expression of Semaphorins 4A, 4B, 
4D and 4G, as well as their respective receptors Plexins B1 and B2 was analyzed 
(Figure 16). Only few cells expressed SEMA4A and were mostly localized within 
or adjacent to the stem cell cluster. SEMA4B was expressed more frequently and 
across all clusters but was most prominent in the clusters associated with the 
absorptive lineage. SEMA4D positive cells were the rarest and mostly restricted 
to the stem cell cluster, as well as the secretory cluster. Cells expressing 
SEMA4G were present in all clusters and relatively evenly distributed, showing 
the highest frequency of the analyzed ligands. Furthermore, the expression of 
two receptors, PLXNB1 and PLXNB2, was investigated. Both were expressed 





Figure 16 Class 4 semaphorins and B-plexins are expressed in the human colonic epithelium. 
Clustering analysis of single-cell RNA sequencing data from human colonic epithelial cells. (A) 
Analysis of SEMA4A, SEMA4B, SEMA4D, SEMA4G expression. (B) Analysis of PLXNB1 and 
PLXNB2 expression. Visualization of data by Mario Looso (MPI, Bad Nauheim). Original sequenc-
ing data (GSE116222) from (Parikh et al., 2019) 
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5.2 Generation of a novel Alpi-Cre2 BAC through homolo-
gous BAC recombination 
The expression analysis of class 4 semaphorins and angiogenin revealed some 
ligands to be restricted to different epithelial compartments e.g., semaphorin 4B 
to the epithelium of the villi and semaphorin 4D to the crypt base. To enable the 
dissection of ligand functions in enterocytes compared to other cell types, a BAC 
was generated by homologous recombination, enabling the enterocyte-specific 
expression of Cre2 recombinase under the control of the Alpi promoter. The BAC 
was then prepared for oocyte injection. The injection, as well as the subsequent 
animal husbandry was performed by collaborators of the Max-Planck Institute for 
Heart and Lung Research (Bad Nauheim). The Alpi-Cre2 expression analysis in 
mT/mG reporter mice was done in collaboration with Josina Großmann as part of 
her bachelor’s thesis. 
 
5.2.1 A Cre2 cassette was recombined into the Alpi gene of a BAC 
A Cre2 donor plasmid was constructed, containing the Cre2 insert flanked by 
homology arms. The full insert was PCR-amplified and integrated into a BAC 
(RP23-49O20), replacing exon 1 of the Alpi gene (Figure 17 A) by homologous 
Red/ET recombination. Correct modification, as well as structural integrity of the 




Figure 17 Successful integration of the Cre2 insert by homologous recombination. (A) Schematic 
of homology-directed BAC recombination; the PCR-amplified Cre2 insert (top) replaced exon 1 of 
the Alpi gene in the BAC RP23-49O20 (middle). The resulting construct is displayed below. (B 
and C) SpeI and XhoI restriction digests respectively of the unmodified BAC (wt) and the recom-
bined BAC (+Cre2); predicted bands from in silico digests are displayed on the left, corresponding 
digest results on the right. 
Both the SpeI and XhoI the recombined BAC (+Cre2) showed the band changes 
predicted in silico, confirming integration of the Cre2 insert (Figure 17 B and C). 
The next step was to remove the bacterial ampicillin resistance used to select for 
the insert. Site-directed FLPase recombination of the BAC was used, and recom-
bination was controlled by restriction digest, comparing an unmodified control 




Figure 18 Successful removal of AmpR by FLPase recombination. (A) Schematic of site-directed 
FLPase BAC recombination; The RP23-49O20-Cre2 BAC (top) was modified by FLPase to re-
move the ampicillin resistance (AmpR), resulting in the final BAC (bottom). (B and C) SpeI and 
XhoI restriction digests respectively of the unmodified BAC (wt) and the FLPase-modified BAC 
(FLPed); predicted bands from in silico digests are displayed on the left, corresponding digest 
results on the right. 
In both the SpeI and XhoI restriction digests, the changes in fragment size corre-
sponded to the changes predicted in silico (Figure 18 B and C respectively). This 
confirmed successful removal of the ampicillin resistance (AmpR) that was ini-
tially part of the insert. This result, as well as the insert sequence were further 




5.2.2 Preparation of the Alpi-Cre2 BAC for oocyte injection 
Next, the Alpi-Cre2 BAC was prepared for oocyte injection by linearization and 
gel permeation chromatography as described in section 4.2.2.3. 
 
Figure 19 Preparation of the Alpi-Cre2 BAC for oocyte injection. (A) The Alpi-Cre2 BAC was 
digested with NotI and separated by gel permeation chromatography using a column assembled 
according to the schematic. (B) The resulting Fractions were separated by agarose gel electro-
phoresis and those enriched with the BAC (▷) were selected for oocyte injection. 
All fractions were characterized by agarose gel electrophoresis to identify the 
fractions containing the highest concentration of the linearized BAC (Figure 19 B, 
empty arrow head). Fractions 4 and 5 were selected for oocyte injection and 
passed on to collaborators at the Max-Planck-Institute for Heart and Lung Re-
search (Bad Nauheim), who performed the oocyte injections and animal hus-
bandry. 
 
5.2.3 Cre recombinase is expressed and functional in transgenic Alpi-
Cre2+ mT/mG+ reporter mice 
The functionality of the Alpi-Cre2 BAC in the intestinal epithelium was validated 
by integration into the genome of mT/mG reporter mice (Muzumdar et al., 2007) ⁠. 
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In these mice, mT codes for dTomato followed by a stop codon and is flanked by 
loxP sites. Downstream lies mG, coding for green fluorescent protein (GFP) (Fig-
ure 20). Under basal conditions, cells only express dTomato. Once Cre recom-
binase is present, the mT element of the reporter is excised, including its stop 
codon, subsequently leading to the replacement of dTomato expression by the 
expression of GFP. 
 
Figure 20 Basic principle of the mT/mG reporter locus. Adapted from (Muzumdar et al., 2007). 
Since the Cre2 construct is integrated into the Alpi gene, its expression is con-
trolled by the gene’s regulatory elements and is only produced, once the gene is 
actively transcribed. The recombinase then mediates the excision of dTomato 
and expression of GFP marks the cells in which Cre is expressed and active. This 
allows (a) the identification of cells, where the Alpi gene is expressed and (b) cell 
type-specific modification of these cells in mice that carry additional loxP sites, 
enabling e.g., the generation of cell type-specific gene knockouts.  
Expression and functionality of the Cre2 recombinase was characterized in the 
small and large intestines of mT/mG reporter mice in collaboration with Josina 
Großmann, who performed the analysis as part of her bachelor’s thesis (Figure 
21). In the small intestine, only single crypts or small clusters of crypts showed 
Cre2 activity as indicated by GFP expression, while the majority of crypts did not 
(Figure 21 A, top panels). In the GFP-positive crypts, most cells were strongly 
expressing GFP except for cells in the crypt base, where GFP intensity was lower. 
Control animals analyzed in the same manner displayed no GFP expression and 
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thus no Cre2 activity (Figure 21 A, bottom panels). In the large intestine, expres-
sion was distributed similarly with GFP-positive crypts forming small clusters, 
while no GFP was visible in the colons of AlpiCre2- control mice. No difference in 
GFP intensity was observable between multiple cells within a single positive crypt 
(Figure 21 B). 
 
 
Figure 21 Analysis of intestinal Alpi-Cre2 expression in mT/mG reporter mice. AlpiCre2+ and Al-
piCre2- control mice were analyzed for Cre2 expression. (A) Cryosections of the small intestine 
and (B) large intestine. DAPI counterstaining. Scale bar: 50 μm. 
Analysis performed in collaboration with Josina Großmann as part of her bachelor’s thesis. 
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5.3 Function of class 4 semaphorins and B-plexins in the 
intestinal epithelium 
To assess a potential regulatory role semaphorin-plexin signaling in intestinal ep-
ithelial homeostasis, stem cell function was tested in ligand and receptor knock-
out organoids. 
 
5.3.1 Sema4B single knockout and plexin B1/B2 double knockout  
organoids display intestinal stem cell defects 
A functional analysis of organoids derived from semaphorin 4A, 4B, 4D and 4G 
knockout mice, as well as of plexin B1/B2 double knockout mice and their respec-
tive control mice was carried out. Crypts were isolated, seeded and after 5 days 
of culture, the number of organoids, as well as their size and morphology was 
assessed using brightfield imaging and OrganoSeg (Figure 22) (Borten et al., 
2018). 
 





Figure 23 Intestinal stem cell function is reduced in Sema4B single knockout and plexin B1/B2 
double knockout organoids. Organoid formation (% of crypts growing into organoids), area (2D-
area measured in pixels) and perimeter to area ratio analyzed from knockout and control organ-
oids. (A) 3 vs. 3 (Sema4a), 4 vs. 4 (Sema4b), 2 vs. 2 (Sema4d) and 4 vs. 4 (Sema4g) control and 
KO animals, respectively. (B) 2 vs. 2 control and plexin B1/B2 double knockout animals analyzed. 
PB1/2: plexin B1/B2; DKO: double knockout. Bar graphs: mean ± s.d.; Statistical significance: 
Unpaired t-test, * p<0.05; **** p<0.0001. Box plots after the Tukey method: Whiskers extend to 
1.5 times the interquartile range. 
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Organoid seeding efficiency, i.e., the ratio of growing organoids to initially seeded 
crypts, was significantly reduced in Sema4B knockout organoids but remained 
unchanged in Sema4A, Sema4D and Sema4G knockout organoids when com-
pared to control cells analyzed in parallel (Figure 23 A). The size of the organoids 
as measured by their 2-dimensional area was unaffected in the Sema4A, 
Sema4B and Sema4G knockout organoids. The morphological analysis of the 
Sema4D knockout organoids was hindered by tissue debris left over from the 
isolation, although visual inspection revealed no observable differences to the 
control organoids (Figure 23 A). Since class B plexins represent the receptors to 
the analyzed semaphorin ligands, plexin B1 and B2 double knockout (DKO) or-
ganoids were examined as well. Like for the ligand knockout cells, organoid for-
mation was assessed and was substantially lower in the crypts derived from 
plexin B1/B2 DKO mice when compared to control crypts but did grow into larger 
organoids. Their morphology was changed as well, as indicated by a lowered 





5.3.2 Lowered Lgr5 expression in the intestines of angiogenin knock-
out mice points to a possible loss of stem cells 
To investigate the functional role of Ang in intestinal epithelial homeostasis, dif-
ferentiation was analyzed by quantifying the expression of cell type markers in 
small intestinal tissue from angiogenin knockout mice by RTqPCR. Since live tis-
sue was not available, organoid experiments could not be conducted. RNA iso-
lated from whole intestinal tissue was provided by Michael Mazzola (Center for 
Regenerative Medicine, Massachusetts General Hospital; Boston, USA), who 
also confirmed the animal’s genotype by PCR and ELISA for angiogenin. 
 
Figure 24 RTqPCR reveals reduction of stem cells in angiogenin knockout tissue. RNA isolated 
from the whole small intestines of 4 control and 4 angiogenin knockout animals was analyzed for 
the expression of Ang and a panel of intestinal epithelial differentiation markers. Mean ± S.E.M.; 
n=2. Stem cells: Lgr5; Paneth cells: Lyz1, Defa6; Goblet cells: Muc2, RetnlB; Tuft cells: Dclk1, 
Trpm5; EECs: ChgA; Enterocytes: Alpi, Hes1; Proliferation: Ki67. 
RNA provided by Michael Mazzola. 
qPCR revealed no difference in the expression of angiogenin mRNA and prolif-
eration appeared unchanged between control and knockout tissue as well. The 
markers Lgr5 (stem), Muc2 (goblet), Dclk1, Trpm5 (Tuft) and Alpi (enterocytes) 
were reduced in knockout tissue, while Lyz1 (Paneth) and RetnlB (goblet) were 

























































5.4 Establishment of lentiviral transductions of intestinal or-
ganoids 
 
Figure 25 Lentiviral transductions of intestinal organoids. 
Given the fact, that knockout mice were not available for all genes of interest, 
another method was required to investigate ligand function in the intestinal epi-
thelium. Since intestinal organoids proved to be a versatile and powerful tool in 
modeling ISC function, lentiviral transduction of short hairpin RNAs (shRNAs) into 
organoids was chosen to modulate gene expression and conduct functional ex-
periments (Koo et al., 2012; van Lidth de Jeude et al., 2015). The plasmid system 
used to generate the virus particles was based on a doxycycline-inducible Tet on 
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vector (Gossen et al., 1995). Upon induction, cells express both the shRNA, as 
well as GFP. Inducibility was critical since a constitutive knockdown carries the 
risk of making an organoid line non-viable and continued culture might select for 
cells that successfully compensated for the loss of expression of the target gene. 
The sequences targeting Sema4A, were selected based on screening experi-
ments in CMT-93 cells, that were conducted by Inga Shcheglova as part of her 
bachelor’s thesis: Multiple sequences targeting Sema4A were transfected and 
target gene expression was analyzed by RTqPCR. Whichever sequence reduced 
target gene expression the most was chosen for cloning into the inducible vector 
and subsequent organoid transductions.  
Generating transgenic organoids by lentiviral transduction is a complex multi-step 
process (Figure 25). For the culture of murine small intestinal organoids only en-
dogenous Wnt ligand produced by Paneth cells is strictly required. In preparation 
for the transduction, intestinal organoids were seeded and stimulated with Wnt3a-
conditioned medium, which drastically changed organoid morphology. Under Wnt 
stimulation, organoids appearance was cyst-like, and the epithelium remained 
flat instead of becoming columnar. The characteristic crypt-like protrusions did 
not form, possibly because the addition of Wnt ligand prevented the symmetry-
braking events, that precede their formation. The lack of architectural complexity 
indicated a more homogeneous cellular composition, likely consisting of mostly 
LGR5+ stem and early progenitor cells. Since stem and progenitor cells are gen-
erally most capable to give rise to new organoids, increasing their number was 
required to receive enough organoids after the transduction. After three days of 
Wnt3a stimulation, organoids were harvested and processed into a single cell 
suspension. This enabled a clonal outgrowth of new organoids following trans-
duction. Lentiviral supernatant was generated in parallel and combined with the 
single cell suspension, followed by a process termed spinoculation, a 60-minute-
long centrifugation step at low speed. After this, the cell-virus suspension was 
incubated for six hours, the cells were collected and seeded into Matrigel. In the 
initial culture medium Wnt3a stimulation was maintained for another three days 
to supplement endogenous Wnt ligand production. This was done to promote 
stemness, which overall improved cell survival and organoid growth. After that 
time period, organoids had already formed and Wnt3a was removed from the 
culture medium. Antibiotics were added to the medium to select transduced 
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organoids until a control well was free of proliferating cells, followed by an out-
growth period, during which organoids regained their crypt-villus morphology, 
usually within 14 days. 
 
Figure 26 Lentiviral transduction yields a high number of transduced intestinal organoids. Exem-
plary images of intestinal organoids transduced with a doxycycline-inducible construct containing 
both an shRNA sequence and GFP. Images taken after 5 days of culture. Scale bar: 0.1 cm. BF: 
Brightfield, EDOF: Extended depth of field. 
An important improvement to the protocol was made based on experiences with 
cultivating human organoids: Instead of PBS, BSA-PBS was used to resuspend 
cells, which prevented them from sticking to plastic or glass surfaces, substan-
tially increasing the numbers of recovered cells. This was especially crucial dur-
ing preparation for the transduction and subcultivation after selection, when only 
few organoids grew. After transfection and selection, organoids grew well and 
regained their crypt-villus architecture. In the absence of doxycycline, inspection 
with a microscope showed very low levels of GFP fluorescence (Figure 26, top 
panels), indicating low levels of background expression. Upon induction with 
doxycycline over as little as 24 h GFP fluorescence increased dramatically in a 
large percentage of organoids, confirming a high rate of infection. GFP reporter 
expression was monitored for up to seven days and remained stable when 
doxycycline was supplied with the culture medium, indicating stable integration 
into the cell's genome. Exemplary images after 5 days of culture are shown in 
Figure 26 (bottom panels). 
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5.4.1 shRNA-mediated knockdown in organoids is a powerful tool to 
study gene function 
As part of a collaboration with the group of Ralf Jacob (Institute of Cell Biology 
and Cell Pathology, Marburg) and as a proof-of-concept, the lentiviral shRNA ex-
pression system was used to generate tubulin tyrosine ligase (TTL) knockdown 
organoids. TTL mRNA expression was quantified and functional organoid exper-
iments analyzing growth and morphology were carried out. 
 
5.4.1.1 Induction of shRNA expression reduces TTL mRNA-expression in 
murine intestinal organoids 
The relative mRNA expression of murine intestinal TTL knockdown organoids 
was quantified using RTqPCR. 
 
Figure 27 TTL expression is reduced in shTTL-expressing intestinal organoids. Relative TTL 
mRNA expression in scrambled (shscr) control organoids and TTL knockdown organoids (shTTL) 
in the presence (+dox) or absence (-dox) of doxycycline after 96 h of culture. Values were calcu-
lated relative to shscr -dox control. Measured by RTqPCR. Mean ± s.d., n=3. Statistical signifi-
cance: Student's t-test, * p<0.05. 
Upon doxycycline induction for 96 h, a significant reduction in TTL mRNA expres-
sion was observable in the shTTL organoids, while expression in the control or-
ganoids was unaffected (Figure 27). Protein expression was analyzed by mem-
bers of the laboratory of Ralf Jacob using western blotting and confirmed a re-
duction of TTL. Furthermore, the product of the reaction catalyzed by TTL, tyro-
sinated tubulin, was reduced as well, confirming a functional knockdown (data 











































5.4.1.2 Organoid size and structural complexity are reduced in TTL knock-
down organoids 
After confirming the ability of the shRNA constructs to reduce TTL expression in 
intestinal organoids, functional experiments were conducted, culturing organoids 
for 168 h in total. 
 
Figure 28 TTL knockdown strikingly changes intestinal organoid morphology. Scrambled control 
and shTTL knockdown organoids under doxycycline treatment. Representative images after 
168 h. A second independent experiment was conducted for 96 h, showing similar morphology. 
Scale bar low magnification: 1 mm; high magnification: 250 μm. 
Upon induction, organoids remained visibly smaller and displayed a lower level 
of structural complexity. Crypt-like protrusions failed to form, and the epithelium 




Figure 29 Knockdown of TTL reduces intestinal organoid size. shTTL knockdown and scrambled 
(shscr) control organoids were cultivated for 168 h and imaged every 24 h with (+dox) or without 
(-dox) doxycycline treatment. (A) 2D-area of organoids measured in pixels and (B) 2D-perimeter 
of organoids measured in pixels. Box plots after the Tukey method: Whiskers extend to 1.5 times 
the interquartile range; two-way ANOVA, **p<0.0021, ***p<0.0002, ****p<0.0001. 
Organoid size was quantified for all time points by analysis of the 2D area and 
perimeter (Figure 29). All organoid cultures continued to grow over the course of 
the entire experiment. While both control organoids (shscr) and non-induced 
shTTL organoids grew at similar rates, the knockdown of TTL noticeably slowed 
organoid growth as early as 72 h after seeding and the difference in area and 




Figure 30 Morphological complexity of TTL knockdown organoids is reduced. shTTL knockdown 
and scrambled (shscr) control organoids were cultivated for 168 h and imaged every 24 h with 
(+dox) or without (-dox) doxycycline treatment. (A) Perimeter to area ratio as calculated for each 
organoid individually. (B) Eccentricity, i.e., the ratio of the distance between foci of ellipse and 
major axis length. Box plots after the Tukey method: Whiskers extend to 1.5 times the interquartile 
range; two-way ANOVA, *p<0.0332, **p<0.0021, ***p<0.0002, ****p<0.0001. 
To quantify the noticeable reduction in structural complexity, the ratio of perimeter 
to area, as well as eccentricity were analyzed (Figure 30). As the organoids grew, 
the perimeter to area ratio decreased under all conditions, but did so more slowly 
in TTL knockdown organoids. In addition, measured values were distributed more 
widely, pointing to a morphologically more heterogeneous population of organ-
oids. Eccentricity is the ratio of the distance between the foci and major axis 
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length of an ellipse laid over an organoid. It is lower, when organoids are approx-
imately circular and increases as their overall shape becomes less so. At seeding, 
eccentricity was comparable under both control and knockdown conditions and 
decreased over the first 72 h of culture, as organoids became more spherical and 
grew. Starting at 96 h of culture, eccentricity started to increase again under con-
trol conditions as organoids broke symmetry and crypt-like protrusions started to 
grow. Under knockdown conditions eccentricity remained low, reflective of the 
observed lack of crypt-like protrusions. Data from a second independent experi-





5.4.1.3 No clear trends emerge in the differentiation of TTL knockdown or-
ganoids 
Epithelial differentiation was analyzed using RTqPCR to quantify marker gene 
expression. Expression of TTL mRNA was reduced reliably under doxycycline 
induction as shown previously (Figure 27). Three independent experiments were 
conducted after 96 h of doxycycline induction (Figure 31 A), a second experiment 
was carried out after 168 h of doxycycline treatment (Figure 31 B). 
 
Figure 31 Expression analysis of intestinal epithelial marker genes in TTL knockdown organoids. 
Marker gene mRNA expression levels were measured by RTqPCR in scrambled (shscr) control 
organoids and TTL knockdown organoids (shTTL) in the presence (+dox) or absence (-dox) of 
doxycycline. Values were calculated relative to shscr -dox control. (A) After 96 h (mean ± s.d., 
n=3) or (B) after 168 h of culture (mean, n=1). Stem cells: Lgr5; Paneth cells: Lyz1, Defa6; Goblet 
cells: Muc2; Tuft cells: Dclk1, Trpm5; EECs: ChgA; Enterocytes: Alpi, Hes1; Proliferation: Ki67. 
Overall, no clear trends in differentiation could be identified when cell type mark-
ers were analyzed by RTqPCR. For some genes, induction of the scrambled con-
trol construct already influenced marker expression, e.g., Lgr5, Trpm5 at 96 h. 
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The same was true for non-induced shTTL organoids, in which expression levels 
were sometimes drastically different from the scrambled control organoids, e.g., 
Lgr5, Lyz1, Dclk1, Alpi at 96 h. For the 168 h time point, the control conditions 
provided similarly unpredictable results. 
 
5.4.2 Semaphorin 4A shRNAi reduces expression in CMT-93, but not 
murine intestinal organoids 
To further investigate the functional role of semaphorins in the intestinal epithe-
lium, inducible shRNA constructs targeting Sema4A were used to generate mu-
rine small intestinal knockdown organoids. Due to their high efficiency in CMT-93 
cells, two sequences targeting Sema4A (shSema4A_1, shSema4A_4) were cho-
sen and cloned into the inducible LT3GEPIR vector. To test the knockdown effi-
ciency of the new constructs, they were introduced into both CMT-93 cells and 
murine small intestinal organoids by lentiviral transduction. In parallel, lipofections 
of CMT-93 were carried out with the same constructs as control experiments. 
Relative semaphorin 4A mRNA expression was quantified by RTqPCR. 
After lipofection of the constructs into CMT-93 cells, the construct shSema4A_1 
caused a knockdown upon doxycycline induction. Under control conditions or 
with the second shSema4A_4 construct, Sema4A expression was either margin-
ally decreased or increased, respectively (Figure 32 A). Utilizing lentiviral trans-
duction of CMT-93, expression of Sema4A was slightly decreased in scrambled 
control cells upon induction with doxycycline, but was strongly reduced in 
shSema4A cells, even when doxycycline was not applied (Figure 32 B). Finally, 
the constructs were transduced into intestinal organoids. GFP co-expression un-
der doxycycline treatment was used to evaluate transduction efficiency and indi-
cated a high number of transduced organoids (Figure 32 C, left panel). Despite 
successful selection of the organoids with antibiotics and a high transduction ef-
ficiency, no knockdown of Sema4A was detectable in any of the constructs (Fig-




Figure 32 Lentiviral shSema4A constructs reduce Sema4A mRNA expression in CMT-93, but not 
intestinal organoids. CMT-93 cells or intestinal organoids were transfected of transduced with a 
scrambled (shscr) control or an shRNA-construct targeting Sema4A (shSema4a). Relative 
Sema4A mRNA expression measured by RTqPCR. (A) Transfected CMT-93 cells 48 h post-
transfection with (+dox) or without (-dox) doxycycline induction (mean, n=1). (B) Transduced 
CMT-93 cells after 48 h of culture with (+dox) or without (-dox) doxycycline induction (Mean, n=1). 
(C) Transduced intestinal organoids after 96 h with (+dox) or without (-dox) doxycycline induction 
Left panel: Co-expression of GFP in shSema4A-expressing intestinal organoids after 96 h of cul-




5.5 Establishment of human colonic organoid cultures from 
normal and tumor tissue 
Since organoids are a powerful tool to study both physiological and pathological 
processes under conditions, that closely resemble the situation in vivo, human 
colonic organoids were established from both normal and cancerous tissue as 
described in section 4.1.2. All samples were acquired in cooperation with the De-
partment of Visceral, Thoracic and Vascular Surgery and the Department of Pa-
thology of the University Clinic Gießen and Marburg from CRC patients undergo-
ing surgery to remove their tumor and with their consent. 
 
Figure 33 Establishment of human colonic organoid cultures. Schematic of human colonic organ-
oid culture establishment. Part of a surgically removed colon tumor and corresponding normal 
tissue are used to isolate epithelial tumor cells and crypts, respectively. Both are taken into culture 
and grown out to form organoids. Representative images of a normal organoid (left) and a tumor 
organoid (right). 
Establishing the culture of human intestinal organoids, especially from healthy 
tissue samples proved to be more challenging than the culture of murine intestinal 
organoids, due to several factors: Frequently, the isolation of crypts yielded few 
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viable cells and instead contained mostly differentiated cells incapable of growing 
into organoids. Adjustments to the isolation protocol were made based on rec-
ommendations from the group of Kim Bak Jensen (BRIC; Copenhagen, Den-
mark) and led to a considerable increase in the number of stem cells obtained 
from the procedure, a prerequisite for sustainable organoid cultures. Nonethe-
less, efficiency varied from sample to sample, and incubation times in the chela-
tion solution often needed to be adjusted, as short incubation times yielded mostly 
debris, while longer incubation times jeopardized viability of the isolated cells. 
Due to the changes made to the protocol, the initial number of growing structures 
increased, but organoids often failed to entirely close and most cells ceased to 
proliferate after 3 to 4 days. Consequently, subcultivation was at first not suc-
cessful and cells that seemingly survived the process quickly underwent apopto-
sis, leading to the disintegration of organoids. In addition, the subcultivation pro-
tocol used up to that point was associated with a high loss of cells, because frag-
mented organoids frequently stuck to glass or plastic surfaces of cell culture ma-
terials. A significant improvement to that protocol was achieved using BSA-PBS 
when resuspending organoids and pipetting cell suspensions, again increasing 
the number of viable cells obtained from all procedures. This later proved critical 
for the successful expansion of the cultures as starting material was usually 
scarce compared to e.g., murine organoids. Finally, culture media requirements 
for human organoids differed from mouse organoids, as previous publications 
already demonstrated. Therefore, certain requirements were known, i.e., the ad-
dition of exogenous Wnt ligands which were supplemented by adding Wnt3a- and 
R-Spondin1-conditioned medium. However, using those media compositions 
proved unsuccessful in maintaining organoid cultures from healthy tissue for 
more than ca. 4 days. A study by Fujii et al. investigated the use of niche-inspired 
growth factors to improve organoid self-renewal and cellular diversity (M. Fujii et 
al., 2018). Based on this publication, the growth factors insulin-like growth factor 
1 (IGF-1) and fibroblast growth factor (FGF) were incorporated into the culture 
medium and substantially improved organoid survival and growth. The changes 
made to these protocols also improved culture conditions of the tumor organoids, 
although the medium composition differed in some ways: Tumor organoids were 
cultured without exogenous Wnt ligands since a constitutive activation of Wnt 
signaling is often the first step in intestinal tumorigenesis. While this did select for 
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tumors with gain-of-function mutations in the Wnt pathway, it more importantly 
ensured that no healthy epithelial cells would start growing, thus preventing con-
tamination.  
In summary, these improvements established isolation and culture conditions un-
der which normal organoids grew well. They reached a relatively large size when 
compared to murine small intestinal organoids but maintained the typical archi-
tecture, consisting of a simple columnar epithelium, forming a central lumen and 
crypt-like protrusions. Organoids derived from cancerous tissue grew drastically 
less structured. No lumen was observable, and the cells appeared to form a com-
pact mass instead of an epithelial monolayer. While the outside surface of organ-
oids is typically smooth, in tumor organoids it was commonly uneven. The lumen 
of healthy organoids started to fill with apoptotic cells after several days of culture 
and became opaque in light microscopy. This was regularly not the case in tumor 
organoids, which remained translucent, possibly indicating fewer cells becoming 
apoptotic (Figure 33). Taken together these features morphologically distinguish 
normal from tumor organoids and recapitulate identifying properties of tumors in 
vivo e.g., dysplasia and a reduction of apoptosis compared to healthy tissue. Ul-
timately, both normal and tumor organoids could be expanded, subcultivated, fro-
zen in liquid nitrogen and continued to grow after thawing, which indicated the 
cultures to be sustainable for extended periods of time, making them suitable for 




6.1 Potential redundant and non-redundant functions of B-
plexins and their ligands in the intestinal epithelium 
The semaphorin-plexin signaling system has been shown to play important roles 
in a variety of tissues, regulating important processes like organ development, 
angiogenesis, immune responses and epithelial architecture while also being rel-
evant in cancer. It is also an extraordinarily complex family of proteins, in which 
most members have multiple interaction partners, as summarized previously 
(Worzfeld & Offermanns, 2014). Its complexity is further increased by the discov-
ery of non-semaphorin ligands like angiogenin (W. Yu et al., 2017). In addition, 
previous studies frequently demonstrated semaphorins to act in a redundant 
manner, e.g. Maier et al. and Xia et al. in the brain and kidney, respectively (Maier 
et al., 2011; Xia et al., 2015). Thus, the methodical dissection of its elements is a 
prerequisite for experiments that aim to reveal the function of semaphorins and 
plexins. 
The first section of this thesis systematically mapped the expression of B-plexin 
ligands and plexin B1 in the intestinal epithelium, a summary of these analyses 
is provided in Figure 34. The smRNA FISH experiments showed plexin B1 to be 
expressed throughout the entire epithelium of the murine small intestine and co-
lon (Figure 14). In addition, the analysis of a previously published scRNA se-
quencing data set by Parikh et al. showed plexin B1 to be expressed in the human 
colonic epithelium (Figure 16 B) (Parikh et al., 2019). Both methods detect 
mRNA, allowing no direct conclusions regarding the protein levels. However, pre-
vious work by another doctoral candidate, Ivana Matković, as well as several 
publications demonstrated plexin B2 to be widely expressed in the small and 
large intestine, providing evidence on both the mRNA and protein level (Meehan 
et al., 2014). Given that plexin B1 and B2 are closely related homologues and 
expressed in the intestinal epithelium, a shared and possibly redundant functional 




Figure 34 Ligands display distinct expression patterns in the intestinal epithelium. For each ligand 
(orange) or receptor (blue), the methods used to examine its expression are indicated (+). 
In this study, intestinal organoids derived from plexin B1/B2 double knockout mice 
were analyzed to examine intestinal epithelial dynamics ex vivo: They formed 
with reduced efficiency and morphological complexity, but grew larger when com-
pared to control organoids (Figure 23 B). The reduction in organoid formation 
likely indicates either a decrease in the number of ISCs or their function, since 
LGR5+ stem cells are significantly more competent at forming organoids than 
LGR5- cells (Sato et al., 2009). The reduced perimeter to area ratio could support 
both explanations: On the one hand, it may be caused by a reduction in the num-
ber of crypt-like protrusions and thus in the number of ISCs, on the other hand, 
shorter crypt-like protrusions might indicate reduced proliferation in the stem cell 
niche. However, the overall larger plexin B1/B2 double-deficient organoids rather 
113 
 
point to an increase in proliferation. Experiments done by a former colleague 
linked the loss of plexins B1 and B2 to a reduced number of LGR5+ ISCs, re-
duced proliferation at the crypt base, but overall hyperproliferation of the epithe-
lium in vivo. Consequently, the organoid experiments reflect these previous ob-
servations and strongly endorse a role of plexin B1 and B2 in the regulation of 
epithelial homeostasis, possibly by supporting stemness.  
Examinations of the renal epithelium might provide indications, how B-plexins 
function in epithelial tissues: Plexin B1 is essential for appropriate embryonic kid-
ney development, despite being co-expressed with plexin B2 (Korostylev et al., 
2008). Plexin B2 on the other hand is globally expressed in the adult kidney 
(Zielonka et al., 2010), where it was shown to be indispensable for epithelial re-
pair upon ischemic injury (Xia et al., 2015), pointing to distinct functional roles. 
However, under physiological conditions Xia et al. found epithelial architecture to 
be unaffected in plexin B1 and B2 single knockout mice, while it was disrupted 
when both receptors were knocked out, likely because one ligand was able to 
compensate the loss of the other, despite their distinct roles (Xia et al., 2015). A 
similar dynamic between these receptors might exist in the intestine, in which 
each receptor is essential under certain conditions e.g., one being most relevant 
during development, while the other is essential in epithelial repair of the adult 
organ. Since the function of plexins has been linked to proliferation, an important 
difference between these organs might lie in their rate of proliferation: Tubular 
epithelial cells are largely quiescent in the adult kidney (Witzgall et al., 1994), 
while the intestinal epithelium has a high cellular turnover (Stevens & Leblond, 
1947). Consequently, the regulation of intestinal epithelial dynamics is crucially 
important, and compensatory mechanisms are likely at play, given the relatively 
normal morphology of plexin B1/B2 double knockout organoids. A systematic 
characterization of the number of ISCs, the rate of proliferation and tissue mor-
phology in receptor single knockout mice and organoids might paint a clearer 
picture, how plexins B1 and B2 complement each other in the intestinal epithe-
lium.  
Further clues regarding the function of semaphorins and plexins in the intestine 
come from the localization of their ligands: Plexins B1 and B2 are receptors to 
class 4 semaphorins, as has been summarized previously (Worzfeld & Offer-
manns, 2014). Furthermore, another study revealed Ang to signal through plexin 
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B2 (W. Yu et al., 2017). Therefore, this thesis systematically mapped the expres-
sion of these B-plexin ligands in the different epithelial compartments of the in-
testine. All analyzed ligands were found to be expressed and the observed pat-
terns, as well as the methods used are summarized in Figure 34.  
Sema4A was analyzed in lacZ reporter mice as well as smRNA FISH, character-
izing promoter activity and mRNA expression, respectively. Despite the lacZ 
staining revealing only weak promoter activity (Figure 8 and Figure 9), the tran-
script was detectable throughout the entire intestinal epithelium by smRNA FISH. 
In the crypt base, no cell type-specificity was discernable (Figure 11). In human 
colonic epithelium, the analyzed scRNA sequencing data showed relatively low 
expression of SEMA4A (Figure 16). Expression did not appear compartmental-
ized, offering little evidence concerning a specific functional role. However, none 
of the methods used give direct evidence regarding Sema4A protein levels. Es-
pecially the high sensitivity of smRNA FISH might be deceiving, as it detects mi-
nute amounts of transcript. To characterize Sema4A function, Sema4A knockout 
organoids were studied and organoid formation, size and morphology were un-
changed (Figure 23). While these findings do not preclude a role for Sema4A in 
intestinal epithelial dynamics, it is likely not the only ligand to act on plexins B1 
and B2, as it failed to reproduce the defects observed in the receptor double 
knockout organoids. As laid out earlier, ligand redundancy is a phenomenon well 
documented in semaphorin-plexin signaling, meaning other ligands are likely 
compensating for the loss of Sema4A. Breeding and analyzing e.g., ligand double 
knockout mice, or generating multiple-knockdown organoids appears to be nec-
essary to fully dissect these redundancies in the intestine. 
The expression analysis conducted as part of this thesis demonstrated Sema4B 
to be expressed in both small and large intestine: The initial lacZ reporter stain-
ings showed high promoter activity in the upper epithelial compartment of the 
small intestine with a marked decrease towards the intestinal crypts (Figure 8). 
This finding was confirmed using IF stainings, where the epithelium of the villi 
was strongly stained for Sema4B, while no staining was detectable in the crypts 
(Figure 10). Similarly, promoter activity was strongest in the colonic luminal epi-
thelium (Figure 9), however no difference in Sema4B protein levels was detecta-
ble in IF stainings (Figure 10). In the human colonic epithelium, SEMA4B-ex-
pressing cells were the most frequent when compared to the other analyzed 
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ligands, a finding that might indicate expression levels to be similar when com-
pared to the mouse colon. In the small intestine, Sema4B is expressed in the 
highly differentiated epithelium of the villi, making it appealing to speculate, that 
it might send pro-differentiation and anti-proliferation signals to neighboring cells. 
However, when analyzing Sema4B knockout organoids, their size and morphol-
ogy was not affected, making a role in the regulation of proliferation unlikely. In-
stead, Sema4B was the only ligand, whose knockout affected organoid formation, 
a process strongly linked to stem cell function (Sato et al., 2009). How Sema4B 
might influence stem cell niche dynamics remains unclear, as its localization 
within the epithelium appears ill-suited to fill that role. A possible mechanism 
might be the proteolytic release of its extracellular domain, that could then reach 
distant target cells, conceivably within the crypt. Proteolytic cleavage has been 
documented for class 4 semaphorins: Hemming et al. specifically identified 
Sema4B as a putative β-secretase target but only provided experimental evi-
dence for the cleavage of Sema4C (Hemming et al., 2009). Studies of other class 
4 semaphorins identified metalloproteases as likely mediators their cleavage (El-
habazi et al., 2001; Nakatsuji et al., 2012). To test whether intestinal Sema4B is 
cleaved, culture supernatants of organoids could be analyzed for the presence of 
its solubilized extracellular domain e.g., by immunoprecipitation. Whether this 
process is of physiological relevance could then be examined e.g., by inhibiting 
putative proteases to prevent Sema4B cleavage, or by adding recombinant 
Sema4B to the culture medium of Sema4B knockout organoids. Especially the 
examination of ISC number and proliferation under these conditions might help 
to understand the observed phenotype. Although the mode of action is unclear, 
the fact that only the Sema4B knockout affected organoid formation makes it an 
interesting target for the generation of multiple knockouts or knockdowns to in-
vestigate ligand redundancies. The expression of Sema4B in the epithelium of 
the villi also makes an enterocyte-specific knockout by e.g., utilizing an Alpi-Cre 
mouse line an appealing approach.  
The least evidence for its expression was obtained for Sema4C, for which only 
lacZ reporter stainings could be performed. The ligand was only weakly ex-
pressed around the crypt-villus border of the SI, most likely in stromal cells (Fig-
ure 8). Additional staining was observable in the crypt base but likely represented 
unspecific background signal since a similar pattern was observable in the wt 
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control. In the proximal colon, expression was localized in a thin ribbon immedi-
ately below the luminal epithelium (Figure 9, upper panel), but interestingly de-
creased in intensity towards the distal parts of the organ (Figure 9, lower panel). 
While these experiments do not allow direct conclusions on the functions of 
Sema4C, its apparent stromal localization in the intestine is intriguing, as it is 
similar to the expression in other organs: Two studies analyzed expression of 
Sema4C in the kidney and found it to be primarily expressed in interstitial cells of 
the medulla, while Xia et al. further observed an upregulation of its expression 
after ischemic injury of the kidneys (Xia et al., 2015; Zielonka et al., 2010). Perälä 
et al. further found Sema4C-plexin B2 signaling to be essential during kidney de-
velopment (Perälä et al., 2011). These studies demonstrate a role in tissue mor-
phogenesis and possibly in its repair, both tasks that Sema4C might fill in the 
intestine as well. Based on the data gathered in this study however, no conclu-
sions can be drawn regarding its intestinal function. Any future investigations 
would certainly need to further characterize its expression. Based on the lacZ 
reporter stainings, it could not be unambiguously concluded, whether the de-
tected Sema4C promoter activity is of epithelial or stromal origin. One approach 
to address this question could be to isolate the intestinal epithelium and compare 
its Sema4C expression against the remaining intestinal tissue by RTqPCR. To 
characterize its expression gradient along the intestine, tissue from different sec-
tions of the organ could be studied in the same fashion. Regarding a functional 
role, Sema4C knockout mice or knockdown organoids could be studied. Another 
option might be the analysis of organoids treated with recombinant Sema4C pro-
tein. This approach could be particularly interesting, as the proteolytic cleavage 
of the extracellular domain of Sema4C has been described previously (Hemming 
et al., 2009), and similar signaling has been described for class 3 semaphorins, 
that are secreted by fibroblasts in the colonic crypt and support epithelial growth 
by signaling through Nrp2 (Karpus et al., 2019).  
In the SI, the expression of Sema4D was restricted to the crypt base, where no 
obvious cell type-specificity was observable. In the colon, only stromal cells dis-
played detectable amounts of Sema4D (Figure 10). The analyzed scRNA se-
quencing data showed only few human colonic epithelial cells positive for 
SEMA4D, most of which localized to the stem cell and secretory clusters (Figure 
16). While this finding possibly highlights discrepancies in SEMA4D expression 
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patterns between species, it cannot be ruled out that the use of different methods 
is the cause: In the murine colon, antibody stainings were used, while scRNA 
sequencing detects mRNA transcripts. To address this open question e.g., IF 
stainings of murine vs. human colonic organoids could be used to further charac-
terize SEMA4D expression, although other studies also found no epithelial 
Sema4D expression in the murine colon (Meehan et al., 2014). Studying potential 
functions of Sema4D, knockout organoids were analyzed. Organoid formation as 
a metric for stem cell function was not negatively affected by the knockout. The 
analysis of organoid morphology was hindered by tissue debris that was carried 
over when seeding the isolated crypts. Given its localization within the epithelium, 
it is attractive to hypothesize that Sema4D may contribute to stem cell niche reg-
ulation. Since both semaphorins and plexins are not only membrane-bound, but 
also expressed in the crypt, signals might be passed between adjacent cells 
within the niche, i.e., ISCs and Paneth cells. However, the knockout of Sema4D 
did not recapitulate the defects observed in the plexin B1/B2 double knockout 
organoids, leading to the conclusion, that Sema4D is either filling a different func-
tional role, or is part of a redundant group of ligands. In the renal tubular epithe-
lium, Xia et al. observed a similar phenomenon, where only a triple ligand knock-
out of Sema4D, Sema4B and Sema4G phenocopied a plexin B2 knockout (Xia 
et al., 2015). In the colon, the observed stromal Sema4D expression likely indi-
cates the presence of intraepithelial γδ T lymphocytes, that were previously de-
scribed to interact with the plexin B2-expressing epithelium and to be essential 
for epithelial repair in a colitis model (Meehan et al., 2014). While a similar inter-
action cannot be excluded in the small intestine, a key difference is the expres-
sion pattern: Unlike the colonic epithelium, the small intestinal epithelium does 
express Sema4D in a highly specific compartment, the crypt base. Therefore, 
further investigation of its function is warranted. Especially potential ligand redun-
dancies be investigated e.g., by generating double knockout mice or double-
knockdown organoids. 
Sema4G was most strongly expressed in the TA zone of the small intestine, while 
expression in the crypt base was observable, but substantially weaker (Figure 
12). Interestingly, ISCs were more frequently expressing Sema4G, than OLFM4-
negative Paneth cells. Similarly, the middle section of the colonic crypts showed 
the strongest expression, while transcript levels in the crypt bottom and luminal 
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epithelium were lower (Figure 12). In the human colonic epithelium, the scRNA 
sequencing data showed SEMA4G to be expressed at the highest rate of all an-
alyzed ligands, albeit without an observable preference for any particular cluster 
(Figure 16). Although scRNA sequencing allows only limited conclusions regard-
ing the localization of SEMA4G-positive cells within the colonic epithelium, their 
even spread across all clusters fits well with the expression in the TA zone, a 
region in which less differentiated progenitor cells of all lineages can be found 
(Spit et al., 2018). Given the fact that Sema4G is predominantly expressed in the 
TA zone, it stands to reason that it might be associated with either epithelial line-
age determination or regulation of proliferation, the two central processes taking 
place there. However, the analysis of Sema4G knockout organoids offered only 
limited clues regarding its function: Organoid formation, size and morphology 
were unaffected by its loss. While at first glance, this finding makes a role in stem 
cell dynamics or regulation of proliferation unlikely, like for most ligands discussed 
here, redundancies are well documented for Sema4G: In the renal tubular epi-
thelium it acts in concert with Sema4B and Sema4D (Xia et al., 2015), and in 
cerebellar development plays a joint role with Sema4C (Maier et al., 2011). 
Therefore, it might fulfill its function together with other ligands, or serve an en-
tirely different role. Based on these findings, further investigations might go into 
two main directions: Firstly, a possible effect of the Sema4G knockout on epithe-
lial differentiation might have remained hidden. To address this e.g., the quantifi-
cation of differentiation markers in knockout vs. wt control tissue might be ana-
lyzed. Secondly, it remains unclear, whether other ligands might compensate for 
the loss of Sema4G. Like for the ligands discussed before, generating double-
knockdown organoids might be a useful tool in identifying these redundancies. 
Due to its prominent localization within the epithelium, Sema4G would be an at-
tractive target for such an investigation. 
The fact that Angiogenin is expressed in the intestine has been known for several 
decades (Weiner et al., 1987). As part of this thesis, its expression specifically in 
the intestinal epithelium was explored: Angiogenin was expressed in the small 
intestine’s crypt base and lower TA zone, but expression levels were relatively 
low. smRNA FISH paired with IF staining for the stem cell marker OLFM4 re-
vealed Ang to be expressed more frequently in Paneth cells, than in stem cells. 
In the colon, Ang expression was low in the crypt, but increased towards the 
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lumen, where epithelial cells showed the strongest expression (Figure 13). While 
no fresh tissue was available to grow organoids, epithelial differentiation was an-
alyzed by RTqPCR in the intestines of Ang knockout mice (Figure 24). Although 
the Ang mRNA levels were unchanged between knockout and control animals, 
samples were analyzed, as the knockout was previously confirmed by genotyping 
PCR and ELISA detecting ANG protein by our collaborator, indicating a functional 
knockout (data not shown). In Ang knockout mice the decreased Lgr5 mRNA 
expression indicated a reduction in stem cells, while the increase in Lyz1 expres-
sion pointed to a compensatory increase in Paneth cells. Based on these findings, 
it is appealing to hypothesize, that ANG secreted by Paneth cells supports stem-
ness in the intestinal epithelium: On the one hand, Paneth cells are known to 
support stemness in the intestine by secreting essential niche factors (Sato, van 
Es, et al., 2011). Since they express ANG more frequently than ISCs, it is likely 
secreted and acts on stem cells via plexin B2 in a paracrine manner. On the other 
hand, ANG is known to support stemness in other cell types, e.g., hematopoietic 
cells: Yu et al. demonstrated ANG treatment to increase the expression of self-
renewal genes e.g., Bmi1 (W. Yu et al., 2017), a gene that has been identified as 
an ISC marker (Sangiorgi & Capecchi, 2008). Furthermore, this thesis demon-
strated that the loss of Ang in knockout mice led to a reduction in the expression 
of the stem cell marker Lgr5. However, Paneth cells are not the only intestinal 
source of ANG. Bai et al. found stromal myeloid cells of the colon to express 
ANG, which signals through plexin B2 and has a protective effect against colitis 
(Bai et al., 2020). Despite that, ANG is usually not added to organoid culture me-
dia, raising the question how stromal ANG affects epithelial homeostasis, as it is 
non-essential to culture primary intestinal epithelial cells (Sato et al., 2013).  
Treating wildtype organoids with recombinant ANG might provide clues regarding 
its function although the effects may be subtle, given its expendability in organoid 
culture. In the same way that endogenous Wnt ligand produced by Paneth cells 
is sufficient to culture murine small intestinal organoids, endogenous expression 
of ANG by Paneth cells may be sufficient to maintain the epithelium.  
A second approach to characterize Angiogenin’s function might be a knockdown 
of Ang in intestinal organoids, as tissue from knockout animals was not available. 
Like for the ligand knockout studies, organoid formation and morphology, as well 
as epithelial differentiation could be studied with these approaches. Overall, the 
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findings discussed here provide evidence for a pro-stemness and pro-survival 
function of ANG in the intestinal epithelium, mediated by plexin B2 as its receptor.  
In summary, these results precisely map the expression of B-plexin ligands in the 
intestinal epithelium and highlight some of their potential roles, as well as their 
likely redundancies, which lays the foundation for further functional studies. Es-
pecially the expression in distinct sections of the intestinal epithelium makes the 
concept of specialized ligand functions in epithelial homeostasis appealing. The 
strongest evidence for a functional role of the semaphorin-plexin system in the 
intestinal epithelium comes from the organoid knockout experiments, which link 
semaphorin-plexin signaling to ISC function. However, redundant semaphorin 
roles must be considered as most single knockouts did not cause obvious phe-
notypes. Such redundancies have been well documented in other organs, e.g., 
the nervous system and the kidney (Basile et al., 2006; Xia et al., 2015). This 
possibility is further supported by the fact that no epithelial compartment ex-
pressed only a single ligand. Beyond that, Sema4A, Sema4C, and Sema4D are 
known to act as receptors as well, a characteristic that will need to be explored 
further (Gurrapu et al., 2019; Sun et al., 2017; Zhou et al., 2017). Additional ex-
periments are needed to fully elucidate the functions of B-plexin ligands in the 
intestinal epithelium, for which obtaining multiple knockout or knockdown organ-
oids may prove crucial. Moreover, treating organoids with recombinant ligands 
might be a viable option to identify their effects on the intestinal epithelium. The 
analysis of organoid culture supernatants for proteolytically cleaved extracellular 
domains of semaphorins might help to elucidate, whether paracrine semaphorin 
signaling might contribute to intestinal epithelial maintenance. 
 
6.2 Generating mouse lines through BAC recombination 
Genetically modified mouse models are a useful tool in investigating the func-
tional role of genes. In knockout animals, potential defects allow conclusions 
about the functional role of the missing genes. Mouse lines that are modified in a 
specific cell type can be especially helpful to identify gene functions within a cer-
tain epithelial compartment. A mouse line expressing an enterocyte-specific, in-
ducible Alpi-CreERT construct has been described previously (Tetteh et al., 
2016). Given the high cellular turnover of the intestinal epithelium (Stevens & 
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Leblond, 1947), an inducible Cre recombinase is not necessarily suitable for all 
experimental setups. Modified cells might be lost from the epithelium before any 
effects can be observed.  
However, a constitutive Alpi-Cre2 mouse line would alleviate this problem. As 
part of this thesis, an Alpi-Cre2 BAC was created by homologous Red/ET and 
FLP-FRT recombination (Figure 17 and Figure 18). Using this BAC, our collabo-
rators successfully established a mouse line, that constitutively expressed Cre2 
under the control of the Alpi promoter. Expression and functionality of the Alpi-
Cre2 construct was then analyzed in Alpi-Cre2+ mT/mG+ reporter mice in collab-
oration with Josina Großmann as part of her bachelor thesis. While the BAC re-
combination and the generation of the mouse line were successful, the analysis 
of reporter mice revealed unexpected results: Based on the switch from dTom to 
GFP expression that indicated Cre activity, only a small fraction of crypt-villus 
axes expressed the Alpi-Cre2 construct (Figure 21). Given that most epithelial 
cells covering the villi are Alpi+ enterocytes, a more widespread expression of 
Cre2 and subsequent switch to GFP would have been expected. Furthermore, in 
GFP+ crypt-villus-axes, GFP was also expressed in the lower crypts, even though 
Alpi expression and Lgr5 expression had previously been found to be mutually 
exclusive (Tetteh et al., 2016). This indicated Cre-mediated recombination in 
early progenitor cells, possibly even Lgr5+ ISCs. Consequently, their differenti-
ated offspring would also carry the modification independently of their lineage. 
Since ISCs give rise to all epithelial cell types (Barker et al., 2007), this would 
essentially eliminate cell type specificity.  
Another possible explanation is provided by the study of Tetteh et al.: They found 
Alpi-positive progenitor cells to be capable of replacing niche cells upon damage 
to the epithelium (Tetteh et al., 2016). However, it does appear unlikely, that un-
der basal conditions, epithelial damage caused progenitor cells to dedifferentiate 
and repopulate lower parts of the crypt. Finally, it remains unclear why only a 
small fraction of crypt-villus axes showed recombination events. Utilizing induci-
ble AlpiCreERT mice, Tetteh et al. observed a gradient of Alpi expression along 
the small intestine: While it was most expressed in the proximal and least ex-
pressed in the distal small intestine, the Alpi transcript was detectable in both 
sections by in situ hybridization (Tetteh et al., 2016). Based on this observation, 
one might hypothesize that the Alpi-Cre2 construct is most strongly expressed in 
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the proximal small intestine and less so in the distal small intestine. However, 
given the previous observation of even early progenitors undergoing Cre-medi-
ated modification, a high Cre efficiency must be assumed, meaning even low 
expression should be sufficient to cause recombination. Furthermore, Cre activa-
tion in the Alpi-Cre2+ mT/mG+ reporter mice was characterized in tissue sections 
from swiss rolls, providing a longitudinal overview over most of the organ and no 
obvious GFP gradient was observed. A genetic mosaic of the Alpi-Cre2 construct 
might be the cause for the observed expression pattern, although thorough gen-
otyping of the analyzed mice likely excludes that possibility.  
Despite these findings, generation of the Alpi-Cre2 BAC and mouse line was suc-
cessful, qualifying this approach for the creation of further transgenic animals. 
However, the suitability of the Alpi-Cre2 construct for enterocyte-specific expres-
sion is drawn into question, as recombination occurred in only few crypts and in 
early progenitor cells. An approach targeting a different part of the Alpi gene might 
alleviate these problems: While the Alpi-Cre2 construct generated as part of this 
thesis replaced the first exon of the Alpi gene, the study by Tetteh et al. introduced 
an IRES-CreERT2 cassette at the STOP codon of the last exon (Tetteh et al., 
2016). This might be a determining factor, although difficult to judge given the 
complexity of gene regulation. Furthermore, the use of alternative enterocyte-
specific genes for a similar approach might be explored: Hes1 for example is a 
central regulator in absorptive lineage determination and could be targeted with 
a comparable strategy. However, in the adult mouse it has been found to be ex-
pressed in proliferating crypt cells, possibly disqualifying it (Jensen et al., 2000). 
Finally, BACs have been used to generate transgenic organoids (Schwank, An-
dersson-Rolf, et al., 2013). This method could potentially be used to verify the 
functionality and specificity of newly recombined BACs before animal experi-




6.3 Intestinal organoids in the study of intestinal epithelial 
function 
Organoids derived from semaphorin single knockout mice were analyzed as part 
of this thesis and proved insufficient to reproduce a plexin B1/B2 knockout phe-
notype (Figure 23). Since this was likely due to ligand redundancy as discussed 
above, a major goal of this thesis was to establish knockdown organoids utilizing 
a lentiviral, inducible shRNA approach. As a proof of concept, the gene TTL was 
targeted in intestinal organoids and the resulting cultures were characterized. 
Transduced organoids were obtained with high efficiency and grew normally 
when expression of the shRNA construct was not induced (Figure 26). Upon in-
duction, TTL mRNA levels were reduced significantly, demonstrating the validity 
of the chosen approach (Figure 27).  
Next, experiments were conducted to investigate ISC function and epithelial dif-
ferentiation by measuring organoid growth and morphology, as well as the ex-
pression of differentiation markers, respectively. Using these approaches, sev-
eral changes could be observed in TTL knockdown organoids: Based on the 
measurement of both their 2D area and perimeter, TTL knockdown organoids 
grew slower than control organoids (Figure 29). This trend was first observable 
72 h after seeding, indicating that organoid development was affected early on. 
Serra et al. found the cellular composition of intestinal organoids to be homoge-
neous during the first 48 h of culture, before Paneth cells emerge and initiate 
symmetry breaking events by establishing the intestinal stem cell niche (Serra et 
al., 2019). From these early niches, the typical crypt-like structures grow out. This 
was reflected by the measurement of organoid eccentricity, which was lowest 
after 48 h of culture i.e., organoids were most spherical. After that, eccentricity 
increased, reflecting their rise in structural complexity (Figure 30). Interestingly, 
the structural complexity of TTL knockdown organoids did not appreciably in-
crease, as crypt-like protrusions failed to form. Thus, one could hypothesize that 
the loss of TTL hinders the formation of the stem cell niche, rather than interfering 
with proliferation directly. As a result, the TA zone, where most mitoses take 
place, cannot develop and organoid growth is substantially hindered. 
Next, the quantification of intestinal differentiation markers by RTqPCR revealed 
no consistent trends (Figure 31), although the structural alterations made 
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changes in cellular composition appear plausible. A possible explanation could 
be a loss of epithelial properties resulting from epithelial-to-mesenchymal transi-
tion (EMT), as Whipple et al. observed a reduction of TTL in cells undergoing 
EMT (Whipple et al., 2010). Therefore, epithelial marker expression may be af-
fected in unpredictable ways. Interestingly, EMT is a process linked to tissue re-
generation (Kalluri & Weinberg, 2009), and Serra et al. found intestinal organoids 
to express regeneration gene signatures during growth (Serra et al., 2019), pos-
sibly linking TTL to these processes. However, evidence for a role of TTL in re-
generation has previously only been provided in injured neurons, where it was 
linked to axonal transport (Song et al., 2015). Furthermore, two technical factors 
might contribute to the challenging detection of differentiation markers: First, the 
amount of sample RNA can be restrictive, as organoid cultures are usually kept 
small due to the cost and time required to maintain them. Second, the expression 
of some epithelial marker genes can be low, making the detection of biologically 
relevant differences between samples more difficult. To address this, future ex-
periments might additionally utilize e.g., histological or immunofluorescence 
stainings of organoids to identify effects on epithelial lineage determination, as 
protocols for these methods are readily available (E. Fujii et al., 2018; O’Rourke 
et al., 2016).  
An interesting strategy for further experiments might also be to characterize 
growth and stem cell niche formation in knockdown organoids during the first 72 h 
after seeding. Utilizing IF stainings, the composition of cell types in knockdown 
organoids could be analyzed to elucidate e.g., whether organoids contain suffi-
cient Paneth cells to initiate niche formation. Since the shRNA expression is in-
ducible, TTL expression could furthermore be restored, answering the question 
whether the observed effects are reversible and organoid growth could be re-
sumed. This could be particularly interesting, as organoids that failed to generate 
stem cells mostly differentiate into enterocytes (Serra et al., 2019). 
To further apply this approach to the study of semaphorin-plexin signaling in the 
intestine, Sema4A was targeted with an shRNA construct in intestinal organoids. 
Sema4A was selected as it is widely expressed in the intestinal epithelium as 
discussed above, and experiments screening for effective shRNA sequences in 
multiple cell lines indicated a high knockdown efficiency. The initial validation of 
the construct in CMT-93 cells was successful and RTqPCR revealed a reduction 
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in Sema4A mRNA levels when the plasmid was transfected (Figure 32 A). Using 
transduction however, the knockdown took effect even when doxycycline was not 
applied to the cells (Figure 32 B). Mutations in the lentiviral plasmids were ruled 
out by sequencing (data not shown). Strikingly, the same did not happen when 
intestinal organoids were transduced (Figure 32 D). Instead no knockdown of 
Sema4A was detectable after doxycycline induction, raising the question how the 
target cell may decisively influence construct efficiency. Although CMT-93 cells 
are of intestinal epithelial origin, these results draw their use as a screening cell 
line into question since the findings from previous experiments did not translate 
well into the organoid model. Instead, it may be necessary to e.g., include other 
intestinal cell lines in the screening experiments, test additional targeting se-
quences, or to screen shRNA sequences in organoids. Despite that, the fact that 
TTL was successfully targeted with the same method demonstrates, that the ap-
proach is in principal suitable.  
Lastly, patient-derived colonic human organoids from both normal and tumor tis-
sue were established with the goal of studying the role of semaphorin-plexin sig-
naling in intestinal cancer. The initial problems establishing working culture con-
ditions highlight the challenges in maintaining these cells: Human organoids are 
generally sensitive to suboptimal culture conditions and handling. A crucial factor 
is the preparation of conditioned media that are used to supply the essential 
growth factors Wnt3a and R-Spondin1 (Sato, Stange, et al., 2011). In the protocol 
used here, conditioned media make up 70 % of the complete culture medium of 
healthy human organoids, underlining the importance of their composition. Even-
tually, normal colonic organoids convincingly resembled the intestinal epithelium, 
forming crypt-like protrusions, while tumor organoids recapitulated known mor-
phological characteristics of tumors ex vivo (Figure 33). Although no functional 
experiments could be conducted with these cells so far, the methods established 
in murine organoids as part of this thesis have proven useful in organoid studies 
and should be transferrable to human organoids.  
Especially the establishment of paired tumor and normal organoids from the 
same patient opens a new avenue of investigation: Examining the expression of 
semaphorins and plexins could be a first approach to identify differences between 
healthy and tumor cells. In this thesis, several candidates have been found to be 
expressed in the colonic epithelium and were previously linked to cancer: 
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SEMA4A germline mutations were identified in hereditary CRCs (Schulz et al., 
2014), a fact that warrants the characterization of its role in non-hereditary tumors 
as well. In breast cancer, Sema4A also increased tumor growth (Gurrapu et al., 
2018). Acting as a receptor to plexin B1, Sema4A furthermore increased migra-
tory behavior in cancer cells (Sun et al., 2017), raising the question if the plexin 
B1-SEMA4A signaling axis might contribute to metastasis in CRC. ANG would 
be another interesting subject of study, as it is known to be highly expressed in 
human CRCs and negatively influence prognosis (Etoh et al., 2000). Although 
little evidence links Sema4B and Sema4G to CRC, both are also expressed in 
the colonic epithelium and may be subject to further investigation.  
Applying the methods established in this thesis, these genes could be targeted 
by shRNA to investigate e.g., whether they influence tumor organoid growth or 
differentiation. In an opposite approach they could also be overexpressed in or-
ganoids, or recombinant protein could be added to the culture medium. Further-
more, organoids generated with these methods could be xenografted into mice, 
a common model to study metastasis (Bleijs et al., 2019). 
In summary, the proof-of-concept experiments characterizing TTL knockdown or-
ganoids demonstrated lentiviral shRNA transductions to effectively modulate tar-
get gene expression. Combined with imaging techniques and expression anal-
yses they enabled monitoring of ISC function, proliferation and differentiation, im-
portant metrics in the study of epithelial homeostasis. Given the high transduction 
efficiency, this method will enable the generation of multi-deficient organoid lines, 
a requirement to investigate the redundancies of B-plexin ligands. When applied 
to human organoids, this model will furthermore enable studies of the sema-
phorin-plexin system in colorectal cancer. Especially the comparison between 
primary CRC organoids and normal organoids from the same patient will yield 
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